Part 4 of 5
Page 61
New Business
B1 |
Trend analysis of PVNBP - discrete |
62 |
B2 |
Trend analysis of PVNBP - cumulative |
63 |
B3 |
Geographical analysis of life, pension and investment sales |
64 |
B4 |
Product analysis of life and pension sales |
65 |
B5 |
Analysis of sales via bancassurance channels |
66 |
B6 |
Geographical analysis of regular and single premiums - life and pensions sales |
67 |
B7 |
Geographical analysis of regular and single premiums - investment sales |
67 |
B8 |
Life and pensions new business - net of tax and non-controlling interest |
68 |
B9 |
Europe analysis of bancassurance and retail sales |
68 |
__________________
Page 62
B1 - Trend analysis of PVNBP - discrete
Present value of new business premiums1
|
1Q09 |
2Q09 |
3Q09 |
4Q09 |
1Q10 |
2Q10 |
% Growth on 1Q10 Sterling |
Life and pensions business |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pensions |
989 |
1,100 |
804 |
859 |
941 |
1,120 |
19% |
Annuities |
475 |
358 |
416 |
648 |
877 |
726 |
(17)% |
Bonds |
713 |
506 |
383 |
422 |
412 |
416 |
1% |
Protection |
245 |
216 |
246 |
258 |
231 |
276 |
19% |
Equity release |
83 |
50 |
80 |
63 |
96 |
99 |
3% |
United Kingdom |
2,505 |
2,230 |
1,929 |
2,250 |
2,557 |
2,637 |
3% |
|
|
|
|
|
|
|
|
France |
1,270 |
1,170 |
1,100 |
1,351 |
1,550 |
1,277 |
(18)% |
Ireland |
187 |
239 |
264 |
382 |
247 |
229 |
(7)% |
Italy |
1,136 |
1,062 |
651 |
758 |
1,567 |
1,485 |
(5)% |
Poland |
351 |
203 |
189 |
336 |
206 |
113 |
(45)% |
Spain |
737 |
508 |
397 |
812 |
590 |
470 |
(20)% |
Other Europe |
112 |
96 |
98 |
114 |
125 |
133 |
6% |
Aviva Europe |
3,793 |
3,278 |
2,699 |
3,753 |
4,285 |
3,707 |
(13)% |
Of which: |
|
|
|
|
|
|
|
Bancassurance |
2,243 |
1,850 |
1,291 |
1,762 |
2,611 |
2,305 |
(12)% |
Retail |
1,550 |
1,428 |
1,408 |
1,991 |
1,674 |
1,402 |
(16)% |
Aviva Europe |
3,793 |
3,278 |
2,699 |
3,753 |
4,285 |
3,707 |
(13)% |
|
|
|
|
|
|
|
|
Delta Lloyd2 |
942 |
838 |
1,055 |
830 |
883 |
849 |
(4)% |
Europe |
4,735 |
4,116 |
3,754 |
4,583 |
5,168 |
4,556 |
(12)% |
|
|
|
|
|
|
|
|
North America |
1,929 |
1,260 |
553 |
803 |
997 |
1,337 |
34% |
|
|
|
|
|
|
|
|
Asia Pacific3 |
325 |
207 |
256 |
307 |
409 |
385 |
(6)% |
Australia |
75 |
91 |
95 |
- |
- |
- |
- |
|
|
|
|
|
|
|
|
Total life and pensions |
9,569 |
7,904 |
6,587 |
7,943 |
9,131 |
8,915 |
(2)% |
|
|
|
|
|
|
|
|
Investment sales4 |
744 |
1,204 |
1,094 |
830 |
1,043 |
1,149 |
10% |
|
|
|
|
|
|
|
|
Total long term saving sales |
10,313 |
9,108 |
7,681 |
8,773 |
10,174 |
10,064 |
(1)% |
1. All references to sales in this announcement refer to the present value of new business premiums (PVNBP) unless otherwise stated. PVNBP is the present value of new regular premiums plus 100% of single premiums
2. Delta Lloyd, which operates in the Netherlands, Belgium and Germany, is managed independently from our other European businesses
3. Asia Pacific excludes the Australian life business that was sold on 1 October 2009
4. Investment sales are calculated as new single premium plus the annualised value of new regular premiums
___________________
Page 63
B2 - Trend analysis of PVNBP - cumulative
|
|
Present value of new business premiums1 |
||||
|
1Q09 YTD |
2Q09 YTD |
3Q09 YTD |
4Q09 YTD |
1Q10 YTD |
2Q10 YTD |
Life and pensions business |
|
|
|
|
|
|
|
|
|
|
|
|
|
Pensions |
989 |
2,089 |
2,893 |
3,752 |
941 |
2,061 |
Annuities |
475 |
833 |
1,249 |
1,897 |
877 |
1,603 |
Bonds |
713 |
1,219 |
1,602 |
2,024 |
412 |
828 |
Protection |
245 |
461 |
707 |
965 |
231 |
507 |
Equity release |
83 |
133 |
213 |
276 |
96 |
195 |
United Kingdom |
2,505 |
4,735 |
6,664 |
8,914 |
2,557 |
5,194 |
|
|
|
|
|
|
|
France |
1,270 |
2,440 |
3,540 |
4,891 |
1,550 |
2,827 |
Ireland |
187 |
426 |
690 |
1,072 |
247 |
476 |
Italy |
1,136 |
2,198 |
2,849 |
3,607 |
1,567 |
3,052 |
Poland |
351 |
554 |
743 |
1,079 |
206 |
319 |
Spain |
737 |
1,245 |
1,642 |
2,454 |
590 |
1,060 |
Other Europe |
112 |
208 |
306 |
420 |
125 |
258 |
Aviva Europe |
3,793 |
7,071 |
9,770 |
13,523 |
4,285 |
7,992 |
Of which: |
|
|
|
|
|
|
Bancassurance |
2,243 |
4,093 |
5,384 |
7,146 |
2,611 |
4,916 |
Retail |
1,550 |
2,978 |
4,386 |
6,377 |
1,674 |
3,076 |
Aviva Europe |
3,793 |
7,071 |
9,770 |
13,523 |
4,285 |
7,992 |
|
|
|
|
|
|
|
Delta Lloyd2 |
942 |
1,780 |
2,835 |
3,665 |
883 |
1,732 |
Europe |
4,735 |
8,851 |
12,605 |
17,188 |
5,168 |
9,724 |
|
|
|
|
|
|
|
North America |
1,929 |
3,189 |
3,742 |
4,545 |
997 |
2,334 |
|
|
|
|
|
|
|
Asia Pacific3 |
325 |
532 |
788 |
1,095 |
409 |
794 |
Australia |
75 |
166 |
261 |
261 |
- |
- |
|
|
|
|
|
|
|
Total life and pensions |
9,569 |
17,473 |
24,060 |
32,003 |
9,131 |
18,046 |
|
|
|
|
|
|
|
Investment sales4 |
744 |
1,948 |
3,042 |
3,872 |
1,043 |
2,192 |
|
|
|
|
|
|
|
Total long term saving sales |
10,313 |
19,421 |
27,102 |
35,875 |
10,174 |
20,238 |
1. All references to sales in this announcement refer to the present value of new business premiums (PVNBP) unless otherwise stated. PVNBP is the present value of new regular premiums plus 100% of single premiums
2. Delta Lloyd, which operates in the Netherlands, Belgium and Germany, is managed independently from our other European businesses
3. Asia Pacific excludes the Australian life business that was sold on 1 October 2009
4. Investment sales are calculated as new single premium plus the annualised value of new regular premiums
____________________
Page 64
B3 - Geographical analysis of life, pension and investment sales
|
Present value of new business premiums1 |
|||
6 months |
6 months |
% Growth |
||
Sterling |
Local2 |
|||
Life and pensions business |
|
|
|
|
|
|
|
|
|
United Kingdom |
5,194 |
4,735 |
10% |
10% |
|
|
|
|
|
France |
2,827 |
2,440 |
16% |
19% |
Ireland |
476 |
426 |
12% |
15% |
Italy |
3,052 |
2,198 |
39% |
43% |
Poland |
319 |
554 |
(42)% |
(47)% |
Spain |
1,060 |
1,245 |
(15)% |
(13)% |
Other Europe |
258 |
208 |
24% |
21% |
Aviva Europe |
7,992 |
7,071 |
13% |
15% |
Delta Lloyd3 |
1,732 |
1,780 |
(3)% |
- |
Europe |
9,724 |
8,851 |
10% |
12% |
|
|
|
|
|
North America |
2,334 |
3,189 |
(27)% |
(25)% |
|
|
|
|
|
China |
235 |
167 |
41% |
46% |
Hong Kong |
79 |
52 |
52% |
58% |
India |
58 |
43 |
35% |
29% |
Singapore |
143 |
90 |
59% |
54% |
South Korea |
201 |
127 |
58% |
41% |
Other Asia |
78 |
53 |
47% |
44% |
Asia Pacific5 |
794 |
532 |
49% |
45% |
Australia5 |
- |
166 |
(100)% |
(100)% |
|
|
|
|
|
Total life and pensions |
18,046 |
17,473 |
3% |
4% |
|
|
|
|
|
Investment sales4 |
|
|
|
|
|
|
|
|
|
United Kingdom |
849 |
418 |
103% |
103% |
|
|
|
|
|
Aviva Europe |
731 |
423 |
73% |
76% |
Delta Lloyd3 |
395 |
357 |
11% |
14% |
Europe |
1,126 |
780 |
44% |
48% |
|
|
|
|
|
Australia |
109 |
65 |
68% |
36% |
Singapore |
108 |
232 |
(53)% |
(55)% |
Asia Pacific5 |
217 |
297 |
(27)% |
(32)% |
Australia5 |
- |
453 |
(100)% |
(100)% |
|
|
|
|
|
Total investment sales |
2,192 |
1,948 |
13% |
6% |
|
|
|
|
|
Total long-term savings sales |
20,238 |
19,421 |
4% |
5% |
1. All references to sales in this announcement refer to the present value of new business premiums (PVNBP) unless otherwise stated. PVNBP is the present value of new regular premiums plus 100% of single premiums
2. Local currency growth rates are calculated based on constant rates of exchange.
3. Delta Lloyd, which operates in the Netherlands, Belgium and Germany, is managed independently from our other European businesses
4. Investment sales are calculated as new single premium plus the annualised value of new regular premiums
5. Asia Pacific excludes the Australian life business that was sold on 1 October 2009
________________
Page 65
B4 - Product analysis of life and pension sales
|
|
Present value of new business premiums1 |
||
6 months |
6 months |
% Growth |
||
Sterling |
Local2 |
|||
Life and pensions business |
|
|
|
|
|
|
|
|
|
Pensions |
2,061 |
2,089 |
(1)% |
(1)% |
Annuities |
1,603 |
833 |
92% |
92% |
Bonds |
828 |
1,219 |
(32)% |
(32)% |
Protection |
507 |
461 |
10% |
10% |
Equity release |
195 |
133 |
47% |
47% |
United Kingdom |
5,194 |
4,735 |
10% |
10% |
|
|
|
|
|
Pensions |
751 |
1,123 |
(33)% |
(32)% |
Savings |
6,670 |
5,255 |
27% |
30% |
Annuities |
35 |
51 |
(31)% |
(30)% |
Protection |
536 |
642 |
(17)% |
(14)% |
Aviva Europe |
7,992 |
7,071 |
13% |
15% |
Delta Lloyd3 |
1,732 |
1,780 |
(3)% |
- |
Europe |
9,724 |
8,851 |
10% |
12% |
|
|
|
|
|
Life |
505 |
374 |
35% |
39% |
Annuities |
1,829 |
2,815 |
(35)% |
(33)% |
Funding agreements |
- |
- |
- |
- |
North America |
2,334 |
3,189 |
(27)% |
(25)% |
|
|
|
|
|
Asia Pacific4 |
794 |
532 |
49% |
45% |
Australia |
- |
166 |
(100)% |
(100)% |
|
|
|
|
|
Total life and pensions |
18,046 |
17,473 |
3% |
4% |
1. Present value of new business premiums (PVNBP) is the present value of new regular premiums plus 100% of single premiums, calculated using assumptions consistent with those used to determine new business contribution.
2. Growth rates are calculated based on constant rates of exchange.
3. Delta Lloyd, which operates in the Netherlands, Belgium and Germany, is managed independently from our other European businesses
4. Asia Pacific excludes the Australian life business that was sold on 1 October 2009
___________________
Page 66
B5 - Analysis of sales via bancassurance channels
|
|
Present value of new business premiums1 |
||
6 months |
6 months |
% Growth |
||
Sterling |
Local2 |
|||
Bancassurance |
|
|
|
|
|
|
|
|
|
United Kingdom - RBS |
498 |
692 |
(28)% |
(28)% |
|
|
|
|
|
France - Credit du Nord |
712 |
647 |
10% |
13% |
|
|
|
|
|
Ireland - Allied Irish Bank |
232 |
195 |
19% |
22% |
|
|
|
|
|
UniCredit Group |
1,686 |
1,094 |
54% |
58% |
Eurovita |
436 |
261 |
67% |
72% |
Unione di Banche |
726 |
695 |
4% |
7% |
Other |
113 |
55 |
105% |
109% |
Italy |
2,961 |
2,105 |
41% |
44% |
|
|
|
|
|
Poland |
6 |
15 |
(60)% |
(63)% |
|
|
|
|
|
Bancaja |
276 |
264 |
5% |
7% |
Caixa Galicia |
92 |
105 |
(12)% |
(10)% |
Unicaja |
255 |
486 |
(48)% |
(46)% |
Caja España |
194 |
152 |
28% |
31% |
Other |
120 |
106 |
13% |
17% |
Spain |
937 |
1,113 |
(16)% |
(13)% |
|
|
|
|
|
Other Europe |
68 |
18 |
278% |
278% |
|
|
|
|
|
Aviva Europe |
4,916 |
4,093 |
20% |
23% |
|
|
|
|
|
Delta Lloyd3 - ABN Amro |
232 |
243 |
(5)% |
(2)% |
|
|
|
|
|
Europe |
5,148 |
4,336 |
19% |
22% |
|
|
|
|
|
North America |
- |
- |
- |
- |
|
|
|
|
|
Asia Pacific |
405 |
253 |
60% |
118% |
|
|
|
|
|
Total life and pensions |
6,051 |
5,281 |
15% |
19% |
|
|
|
|
|
Investment sales4 |
|
|
|
|
|
|
|
|
|
United Kingdom - RBS |
141 |
88 |
60% |
60% |
|
|
|
|
|
Total bancassurance sales |
6,192 |
5,369 |
15% |
19% |
1. Present value of new business premiums (PVNBP) is the present value of new regular premiums plus 100% of single premiums, calculated using assumptions consistent with those used to determine new business contribution.
2. Growth rates are calculated based on constant rates of exchange.
3. Delta Lloyd, which operates in the Netherlands, Belgium and Germany, is managed independently from our other European businesses
4. Investment sales are calculated as new single premium plus annualised value of new regular premiums.
__________________
Page 67
B6 - Geographical analysis of regular and single premiums - life and pensions sales
|
Regular premiums |
|
Single premiums |
||||||||
|
6 months |
Local |
WACF |
Present |
6 months |
WACF |
Present |
|
6 months |
6 months |
Local |
|
|
|
|
|
|
|
|
|
|
|
|
Pensions |
208 |
(8)% |
4.7 |
985 |
225 |
4.9 |
1,095 |
|
1,076 |
994 |
8% |
Annuities |
- |
- |
- |
- |
- |
- |
- |
|
1,603 |
833 |
92% |
Bonds |
- |
- |
- |
- |
- |
- |
- |
|
828 |
1,219 |
(32)% |
Protection |
79 |
8% |
6.4 |
507 |
73 |
6.2 |
452 |
|
― |
9 |
(100)% |
Equity release |
- |
- |
- |
- |
- |
- |
- |
|
195 |
133 |
47% |
United Kingdom |
287 |
(4)% |
5.2 |
1,492 |
298 |
5.2 |
1,547 |
|
3,702 |
3,188 |
16% |
|
|
|
|
|
|
|
|
|
|
|
|
France |
54 |
15% |
7.2 |
389 |
47 |
6.8 |
321 |
|
2,438 |
2,119 |
18% |
Ireland |
36 |
(3)% |
4.1 |
146 |
38 |
4.6 |
176 |
|
330 |
250 |
35% |
Italy |
37 |
(51)% |
5.2 |
191 |
78 |
6.7 |
519 |
|
2,861 |
1,679 |
75% |
Poland |
29 |
(34)% |
9.4 |
273 |
41 |
11.4 |
467 |
|
46 |
87 |
(51)% |
Spain |
59 |
(8)% |
5.6 |
333 |
65 |
5.8 |
379 |
|
727 |
866 |
(14)% |
Other Europe |
43 |
- |
4.8 |
207 |
42 |
4.4 |
185 |
|
51 |
23 |
122% |
Aviva Europe |
258 |
(17)% |
6.0 |
1,539 |
311 |
6.6 |
2,047 |
|
6,453 |
5,024 |
32% |
Delta Lloyd1 |
87 |
(12)% |
10.1 |
878 |
102 |
9.5 |
972 |
|
854 |
808 |
9% |
Europe |
345 |
(16)% |
7.0 |
2,417 |
413 |
7.3 |
3,019 |
|
7,307 |
5,832 |
28% |
|
|
|
|
|
|
|
|
|
|
|
|
North America |
49 |
20% |
10.2 |
502 |
42 |
8.8 |
370 |
|
1,832 |
2,819 |
(33)% |
|
|
|
|
|
|
|
|
|
|
|
|
Asia Pacific2 |
119 |
24% |
4.4 |
527 |
92 |
4.3 |
399 |
|
267 |
133 |
101% |
Australia |
― |
(100)% |
― |
― |
30 |
4.1 |
124 |
|
― |
42 |
(100)% |
|
|
|
|
|
|
|
|
|
|
|
|
Total life and pensions |
800 |
(9)% |
6.2 |
4,938 |
875 |
6.2 |
5,459 |
|
13,108 |
12,014 |
11% |
1. Delta Lloyd, which operates in the Netherlands, Belgium and Germany, is managed independently from our other European businesses
2 Asia Pacific excludes the Australian life business that was sold on 1 October 2009
B7 - Geographical analysis of regular and single premiums - investment sales
|
Regular2 |
|
Single |
|
PVNBP |
||||
6 months |
6 months |
Local |
|
6 months |
6 months |
Local |
|
Local |
|
Investment sales |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United Kingdom |
43 |
34 |
26% |
|
797 |
374 |
113% |
|
103% |
|
|
|
|
|
|
|
|
|
|
Aviva Europe |
3 |
3 |
- |
|
728 |
420 |
78% |
|
76% |
Delta Lloyd1 |
- |
- |
- |
|
395 |
357 |
14% |
|
14% |
Europe |
3 |
3 |
- |
|
1,123 |
777 |
48% |
|
48% |
|
|
|
- |
|
|
|
|
|
|
Australia |
- |
- |
- |
|
109 |
65 |
36% |
|
36% |
Singapore |
- |
- |
- |
|
108 |
232 |
(55)% |
|
(55)% |
Asia Pacific |
- |
- |
- |
|
217 |
297 |
(32)% |
|
(32)% |
Australia3 |
- |
- |
- |
|
- |
453 |
(100)% |
|
(100)% |
|
|
|
|
|
|
|
|
|
|
Total investment sales |
46 |
37 |
24% |
|
2,137 |
1,901 |
6% |
|
6% |
1. Delta Lloyd, which operates in the Netherlands, Belgium and Germany, is managed independently from our other European businesses
2. UK regular premium investment sales include SIPP products. These are similar in nature to pension products and their payment pattern is stable and predictable and accordingly they have been capitalised. Regular premium SIPP sales for the 6 months to 30 June 2010 totalled £1.9 million (2009: £2.3 million) and have been capitalised using a weighted average capitalisation factor of 5.0 (2009: 5.0). As such, regular premium SIPP sales have produced an overall contribution to investment sales of £9.4 million (2009: £11.5 million) out of the UK investment sales of £849 million (2009: £418 million)
3. Asia Pacific excludes the Australian life business that was sold on 1 October 2009
___________
Page 68
B8 - Life and pensions new business - net of tax and non-controlling interest
|
Present value of new |
|
Value of new business |
|
New business margin |
|||||||
Life and pensions |
6 months 2010 |
6 months |
Full year |
|
6 months 2010 |
6 months |
Full year |
|
6 months 2010 |
6 months |
Full year |
|
United Kingdom |
5,194 |
4,735 |
8,914 |
|
126 |
72 |
177 |
|
2.4% |
1.5% |
2.0% |
|
|
France |
2,367 |
2,019 |
4,111 |
|
58 |
40 |
94 |
|
2.5% |
2.0% |
2.3% |
|
Ireland |
356 |
320 |
804 |
|
1 |
3 |
8 |
|
0.3% |
0.9% |
1.0% |
|
Italy |
1,351 |
994 |
1,614 |
|
24 |
25 |
38 |
|
1.8% |
2.5% |
2.4% |
|
Poland |
279 |
480 |
933 |
|
14 |
19 |
39 |
|
5.0% |
4.0% |
4.2% |
|
Spain |
580 |
676 |
1,326 |
|
22 |
26 |
51 |
|
3.8% |
3.8% |
3.8% |
|
Other Europe |
259 |
208 |
420 |
|
10 |
5 |
8 |
|
3.8% |
2.4% |
1.9% |
|
Aviva Europe |
5,192 |
4,697 |
9,208 |
|
129 |
118 |
238 |
|
2.5% |
2.5% |
2.6% |
|
Delta Lloyd |
937 |
1,661 |
3,235 |
|
(25) |
(28) |
(78) |
|
(2.7)% |
(1.7)% |
(2.4)% |
|
Europe |
6,129 |
6,358 |
12,443 |
|
104 |
90 |
160 |
|
1.7% |
1.4% |
1.3% |
|
North America |
2,334 |
3,189 |
4,545 |
|
2 |
16 |
16 |
|
0.1% |
0.5% |
0.4% |
|
Asia Pacific |
787 |
694 |
1,348 |
|
14 |
12 |
22 |
|
1.8% |
1.7% |
1.6% |
Total life and pensions |
14,444 |
14,976 |
27,250 |
|
246 |
190 |
375 |
|
1.7% |
1.3% |
1.4% |
|
B9 - Aviva Europe analysis of bancassurance and retail sales
Cumulative |
Bancassurance |
|
|
|
Retail |
|
|
|
Total |
||
|
6 months |
6 months |
Local |
|
6 months |
6 months |
Local |
|
6 months |
6 months |
Local currency growth |
Life and pensions |
|
|
|
|
|
|
|
|
|
|
|
France |
712 |
647 |
13% |
|
2,115 |
1,793 |
21% |
|
2,827 |
2,440 |
19% |
Ireland |
232 |
195 |
22% |
|
244 |
231 |
8% |
|
476 |
426 |
15% |
Italy |
2,961 |
2,105 |
44% |
|
91 |
93 |
- |
|
3,052 |
2,198 |
43% |
Poland |
6 |
15 |
(63)% |
|
313 |
539 |
(46)% |
|
319 |
554 |
(47)% |
Spain |
937 |
1,113 |
(13)% |
|
123 |
132 |
(5)% |
|
1,060 |
1,245 |
(13)% |
Other Europe |
68 |
18 |
278% |
|
190 |
190 |
(3)% |
|
258 |
208 |
21% |
Aviva Europe |
4,916 |
4,093 |
23% |
|
3,076 |
2,978 |
4% |
|
7,992 |
7,071 |
15% |
Discrete quarter |
Bancassurance |
|
|
|
Retail |
|
|
|
Total |
|
||
|
2Q |
1Q |
Local |
|
2Q |
1Q |
Local |
|
2Q |
1Q |
Local currency growth |
|
Life and pensions |
|
|
|
|
|
|
|
|
|
|
|
|
France |
319 |
393 |
(17)% |
|
958 |
1,157 |
(16)% |
|
1,277 |
1,550 |
(16)% |
|
Ireland |
115 |
117 |
- |
|
114 |
130 |
(11)% |
|
229 |
247 |
(6)% |
|
Italy |
1,419 |
1,542 |
(6)% |
|
66 |
25 |
169% |
|
1,485 |
1,567 |
(4)% |
|
Poland |
3 |
3 |
10% |
|
110 |
203 |
(40)% |
|
113 |
206 |
(39)% |
|
Spain |
407 |
530 |
(22)% |
|
63 |
60 |
7% |
|
470 |
590 |
(19)% |
|
Other Europe |
42 |
26 |
62% |
|
91 |
99 |
(8)% |
|
133 |
125 |
6% |
|
Aviva Europe |
2,305 |
2,611 |
(10)% |
|
1,402 |
1,674 |
(14)% |
|
3,707 |
4,285 |
(12)% |
_______________________________
Page 69
Capital Management
C1 |
Capital management objectives and approach |
70 |
C2 |
Group capital structure |
72 |
C3 |
Analysis of return on capital employed |
|
|
C3 i - Analysis of IFRS return on capital employed |
74 |
|
C3 ii - Analysis of MCEV return on capital employed |
75 |
C4 |
Capital generation and utilisation |
77 |
C5 |
Capital required to write new business, internal rate of return and payback period |
78 |
C6 |
Regulatory capital |
79 |
C7 |
IFRS Sensitivity analysis |
81 |
_____________________
Page 70
C1 - Capital management objectives and approach
Aviva's capital management philosophy is focused on capital efficiency and effective risk management to support the dividend policy and earnings per share growth. Overall capital risk appetite is set and managed with reference to the requirements of a range of different stakeholders including shareholders, policyholders, regulators and rating agencies. In managing capital we seek to:
- maintain sufficient, but not excessive, financial strength to support new business growth and satisfy the requirements of our regulators and other stakeholders thus giving both our customers and shareholders assurance of our financial strength;
- optimise our overall debt to equity structure to enhance our returns to shareholders, subject to our capital risk appetite and balancing the requirements of the range of stakeholders;
- retain financial flexibility by maintaining strong liquidity, including significant unutilised committed credit facilities and access to a range of capital markets;
- allocate capital rigorously across the group, to drive value adding growth in accordance with risk appetite; and
- declare dividends on a basis judged prudent, while retaining capital to support future business growth, using dividend cover on an IFRS operating earnings after tax basis in the 1.5 to 2.0 times range as a guide.
Targets are established in relation to regulatory solvency, ratings, liquidity and dividend capacity and are a key tool in managing capital in accordance with our risk appetite and the requirements of our various stakeholders.
Regulatory capital
Individual regulated subsidiaries measure and report solvency based on applicable local regulations, including in the UK the regulations established by the Financial Services Authority (FSA). These measures are also consolidated under the European Insurance Groups Directive (IGD) to calculate regulatory capital adequacy at an aggregate group level, where we have a regulatory obligation to have a positive position at all times. This measure represents the excess of the aggregate value of regulatory capital employed in our business over the aggregate minimum solvency requirements imposed by local regulators, excluding the surplus held in the UK and Ireland with-profit life funds. The minimum solvency requirement for our European businesses is based on the Solvency 1 Directive. In broad terms, for EU operations, this is set at 4% and 1% of non-linked and unit-linked life reserves respectively and for our general insurance portfolio of business is the higher of 18% of gross premiums or 26% of gross claims, in both cases adjusted to reflect the level of reinsurance recoveries. For our major non-European businesses (the US, and Canada) a risk charge on assets and liabilities approach is used.
Rating agency capital
Credit ratings are an important indicator of financial strength and support access to debt markets as well as providing assurance to business partners and policyholders over our ability to service contractual obligations. In recognition of this we have solicited relationships with a number of rating agencies. The agencies generally assign ratings based on an assessment of a range of financial factors (e.g. capital strength, gearing, liquidity and fixed charge cover ratios) and non financial factors (e.g. strategy, competitive position, and quality of management).
Certain rating agencies have proprietary capital models which they use to assess available capital resources against capital requirements as a component in their overall criteria for assigning ratings. Managing our capital and liquidity position in accordance with our target rating levels is a core consideration in all material capital management and capital allocation decisions.
The group's overall financial strength is reflected in our credit ratings. The group's rating from Standard and Poors is AA- ("very strong") with a Negative outlook; Aa3 ("excellent") with a Stable outlook from Moody's; and A ("excellent") with a Stable outlook from A M Best. These ratings continue to reflect our strong competitive position, positive strategic management, strong and diversified underlying earnings profile and robust liquidity position.
________________________
Page 71
C1 - Capital management objectives and approach continued
Economic capital
We use a risk-based capital model to assess economic capital requirements and to aid in risk and capital management across the group. The model is based on a framework for identifying the risks to which business units, and the group as a whole, are exposed. A mixture of scenario based approaches and stochastic models are used to capture market risk, credit risk, insurance risk and operational risk. Scenarios are specified centrally to provide consistency across businesses and to achieve a minimum standard. Where appropriate, businesses also supplement these with additional risk models and stressed scenarios specific to their own risk profile. When aggregating capital requirements at business unit and group level, we allow for diversification benefits between risks and between businesses, with restrictions to allow for non-fungibility of capital when appropriate. This means that the aggregate capital requirement is less than the sum of capital required to cover all of the individual risks.
This model is used to support our Individual Capital Assessments (ICA) which are reported to the FSA for all our UK regulated insurance businesses. The FSA uses the results of our ICA process when setting target levels of capital for our UK regulated insurance businesses. In line with FSA requirements, the ICA estimates the capital required to mitigate the risk of insolvency to a 99.5% confidence level over a one year time horizon (equivalent to events occurring in 1 out of 200 years) against financial and non-financial tests.
The financial modelling techniques employed in economic capital enhance our practice of risk and capital management.
They enable understanding of the impact of the interaction of different risks allowing us to direct risk management activities appropriately. These same techniques are employed to enhance product pricing and capital allocation processes. Unlike more traditional regulatory capital measures, economic capital also recognises the value of longer term profits emerging from in-force and new business, allowing for consideration of longer term value emergence as well as shorter term net worth volatility in our risk and capital management processes. We continue to develop our economic capital modelling capability for all our businesses as part of our development programme to increase the focus on economic capital management. and meeting the emerging requirements of the Solvency II framework and external agencies.
Solvency II
The development of Solvency II has continued in 2010. Since the approval of the Solvency II Directive in May 2009, the European Commission has focused on developing the technical requirements in the Level 2 implementing measures to provide the detail under Level 1. The European Commission has asked CEIOPS to run a quantitative impact study (QIS5) to test a possible set of technical requirements with the industry. This exercise, which Aviva will participate in, will run between August and November 2010 with a final report by CEIOPS expected to be published in April 2011. Aviva has been actively participating in the development of the technical requirements, of both the implementing measures and the QIS 5 specifications, through the key European industry working groups who provide the voice of industry in on-going negotiation in Brussels and engaging with the FSA and HM Treasury who participate in these negotiations.
European Commission is now giving further consideration to the wording on the implementing measures and is expected to finalise these measures in spring 2011 following the QIS5 exercise. Full implementation of Solvency II is expected to be delayed and required from 1 January 2013.
_________________________
Page 72
C2 - Group capital structure
The table below shows how our capital, on an MCEV basis, is deployed by segment and how that capital is funded.
|
30 June |
31 December 2009 |
Long-term savings |
19,948 |
20,693 |
General insurance and health |
4,744 |
4,562 |
Fund management |
258 |
269 |
Other business |
(127) |
(246) |
Corporate1 |
(35) |
(34) |
Total capital employed |
24,788 |
25,244 |
Financed by |
|
|
Equity shareholders' funds |
12,921 |
13,035 |
Non-controlling interests |
3,885 |
4,237 |
Direct capital instrument |
990 |
990 |
Preference shares |
200 |
200 |
Subordinated debt |
4,486 |
4,637 |
External debt |
872 |
852 |
Net internal debt2 |
1,434 |
1,293 |
Total capital employed |
24,788 |
25,244 |
1. The "corporate" net liabilities represent the element of the pension scheme deficit held centrally.
2. In addition to our external funding sources, we have certain internal borrowing arrangements in place which allow some of the assets that support technical liabilities to be invested in a pool of central assets for use across the group. These internal debt balances allow for the capital allocated to business operations to exceed the externally sourced capital resources of the group. Net internal debt represents the balance of the amounts due from corporate and holding entities, less the tangible net assets held by these entities. Although intra-group in nature, they are included as part of the capital base for the purpose of capital management. These arrangements arise in relation to the following:
- Certain subsidiaries, subject to continuing to satisfy stand alone capital and liquidity requirements, loan funds to corporate and holding entities, these loans satisfy arms length criteria and all interest payments are made when due.
- Aviva International Insurance (AII) Ltd acts as both a UK general insurer and as the primary holding company for our foreign subsidiaries. Internal capital management mechanisms in place allocate a portion of the total capital of the company to the UK general insurance operations. These mechanisms also allow for some of the assets backing technical liabilities to be made available for use across the group. Balances in respect of these arrangements are also treated as internal debt for capital management purposes.
Total capital employed is financed by a combination of equity shareholders' funds, preference capital, subordinated debt and borrowings (including internal borrowings as described in footnote 2 above).
At 30 June 2010 we had £24.8 billion (31 December 2009: £25.2 billion) of total capital employed in our trading operations, measured on an MCEV basis.
Financial leverage, the ratio of external senior and subordinated debt to MCEV capital and reserves, was 31.9% (31 December 2009: 31.8%). If centre assets were offset against this debt the financial leverage would be 21.1% (31 December 2009: 19.0%). Fixed charge cover, which measures the extent to which external interest costs, including subordinated debt interest and preference dividends, are covered by MCEV operating profit was 11.3 times (31 December 2009: 8.5 times).
At 30 June 2010 the market value of our external debt, subordinated debt, preference shares (including both Aviva plc preference shares of £200 million and General Accident plc preference shares, within non-controlling interest, of £250 million), and direct capital instrument was £6,399 million (31 December 2009: £6,634 million), with a weighted average cost of 4.8% (31 December 2009: 5.0%). The group Weighted Average Cost of Capital (WACC) is 7.4% (31 December 2009: 8.0%) and has been calculated by reference to the cost of equity and the cost of debt at the relevant date. The cost of equity at 30 June 2010 was 9.2% (31 December 2009: 9.8%) based on a risk free rate of 3.4% (31 December 2009: 4.0%), an equity risk premium of 4.0% (31 December 2009: 4.0%) and a market beta of 1.5 (31 December 2009: 1.4).
____________________
Page 73
C2 - Group capital structure continued
Shareholders' funds, including non-controlling interest
|
30 June 2010 |
|
31 December 2009 |
||||
|
IFRS |
Internally generated AVIF |
Total |
|
IFRS |
Internally generated AVIF |
Total |
Life assurance |
|
|
|
|
|
|
|
United Kingdom |
4,230 |
1,469 |
5,699 |
|
4,454 |
1,343 |
5,797 |
France |
1,476 |
1,467 |
2,943 |
|
1,707 |
1,386 |
3,093 |
Ireland |
1,188 |
103 |
1,291 |
|
1,139 |
201 |
1,340 |
Italy |
1,232 |
307 |
1,539 |
|
1,405 |
290 |
1,695 |
Poland |
200 |
1,021 |
1,221 |
|
239 |
1,073 |
1,312 |
Spain |
1,207 |
607 |
1,814 |
|
1,288 |
662 |
1,950 |
Other Europe |
353 |
23 |
376 |
|
435 |
(87) |
348 |
Aviva Europe |
5,656 |
3,528 |
9,184 |
|
6,213 |
3,525 |
9,738 |
Delta Lloyd |
3,644 |
(1,280) |
2,364 |
|
2,983 |
(148) |
2,835 |
Europe |
9,300 |
2,248 |
11,548 |
|
9,196 |
3,377 |
12,573 |
North America |
3,512 |
(1,627) |
1,885 |
|
3,072 |
(1,490) |
1,582 |
Asia Pacific |
688 |
128 |
816 |
|
595 |
146 |
741 |
|
17,730 |
2,218 |
19,948 |
|
17,317 |
3,376 |
20,693 |
General insurance and health |
|
|
|
|
|
|
|
United Kingdom |
1,938 |
- |
1,938 |
|
1,876 |
- |
1,876 |
France |
371 |
- |
371 |
|
410 |
- |
410 |
Ireland |
423 |
- |
423 |
|
450 |
- |
450 |
Other Europe |
285 |
- |
285 |
|
329 |
- |
329 |
Aviva Europe |
1,079 |
- |
1,079 |
|
1,189 |
- |
1,189 |
Delta Lloyd |
622 |
- |
622 |
|
545 |
- |
545 |
Europe |
1,701 |
- |
1,701 |
|
1,734 |
- |
1,734 |
North America |
1,077 |
- |
1,077 |
|
928 |
- |
928 |
Asia Pacific |
28 |
- |
28 |
|
24 |
- |
24 |
|
4,744 |
- |
4,744 |
|
4,562 |
- |
4,562 |
Fund management |
258 |
- |
258 |
|
269 |
- |
269 |
Other business |
(127) |
- |
(127) |
|
(246) |
- |
(246) |
Corporate |
(35) |
- |
(35) |
|
(34) |
- |
(34) |
Subordinated debt |
(4,486) |
- |
(4,486) |
|
(4,637) |
- |
(4,637) |
External debt |
(872) |
- |
(872) |
|
(852) |
- |
(852) |
Net internal debt |
(1,434) |
- |
(1,434) |
|
(1,293) |
- |
(1,293) |
|
(6,696) |
- |
(6,696) |
|
(6,793) |
- |
(6,793) |
Shareholders' funds, including non-controlling interests |
15,778 |
2,218 |
17,996 |
|
15,086 |
3,376 |
18,462 |
Less: |
|
|
|
|
|
|
|
Non-controlling interests |
|
|
(3,885) |
|
|
|
(4,237) |
Direct capital instruments |
|
|
(990) |
|
|
|
(990) |
Preference capital |
|
|
(200) |
|
|
|
(200) |
Equity shareholders' funds |
|
|
12,921 |
|
|
|
13,035 |
Less: goodwill and intangibles1 |
|
|
(4,627) |
|
|
|
(4,628) |
Equity shareholders funds' excluding goodwill and intangibles |
|
|
8,294 |
|
|
|
8,407 |
1. Goodwill and intangibles comprise £3,377 million (31 December 2009:£3,381 million) of goodwill in subsidiaries, £1,344 million (31 December 2009: £1,367 million) of intangibles in subsidiaries, £166 million (31 December 2009: £150 million) of goodwill and intangibles in joint ventures and £282 million (31 December 2009: £264 million) of goodwill in associates, net of associated deferred tax liabilities of £279 million (31 December 2009: £271 million) and the minority share of intangibles of £263 million (31 December 2009: £263 million).
_______________________
Page 74
C3 i - Analysis of IFRS return on capital employed
|
30 June 2010 |
|||
|
Operating return1 |
|
Annualised |
|
|
Before tax |
After tax |
||
|
||||
Life assurance |
1,128 |
866 |
17,317 |
10.0% |
General insurance and health |
480 |
346 |
4,562 |
15.2% |
Fund management |
56 |
39 |
269 |
29.0% |
Other business |
(47) |
(31) |
(246) |
25.2% |
Corporate |
(103) |
(84) |
(34) |
494.1% |
Subordinated debt |
(146) |
(105) |
(4,637) |
4.5% |
External debt |
(22) |
(16) |
(852) |
3.8% |
Net internal debt2 |
(76) |
(55) |
(1,293) |
8.5% |
|
1,270 |
960 |
15,086 |
12.7% |
Less: Non-controlling interests |
|
(193) |
(3,540) |
11.0% |
Direct capital instrument |
|
- |
(990) |
- |
Preference capital |
|
(9) |
(200) |
9.0% |
Return on equity shareholders' funds |
|
758 |
10,356 |
14.6% |
1. The operating return is based upon group IFRS operating profit, which is stated before impairment of goodwill, amortisation of intangibles, exceptional items and investment variance.
2. The net internal debt loss before tax of £76 million comprises investment return of £45 million offset by group internal debt costs and other interest of £121 million.
|
31 December 2009 |
|||
|
Operating return1 |
Restated |
Annualised |
|
|
Before tax |
After tax |
||
Life assurance |
1,887 |
1,405 |
16,581 |
8.5% |
General insurance and health |
919 |
660 |
5,516 |
12.0% |
Fund management |
133 |
93 |
340 |
27.4% |
Other business |
(214) |
(152) |
(199) |
76.4% |
Corporate |
(182) |
(156) |
(30) |
520.0% |
Subordinated debt |
(293) |
(211) |
(4,606) |
4.6% |
External debt |
(42) |
(30) |
(919) |
3.3% |
Net internal debt2 |
(186) |
(134) |
(2,110) |
6.4% |
|
2,022 |
1,475 |
14,573 |
10.1% |
Less: Non-controlling interests |
|
(193) |
(2,204) |
8.8% |
Direct capital instrument |
|
(44) |
(990) |
4.4% |
Preference capital |
|
(17) |
(200) |
8.5% |
Return on equity shareholders' funds |
|
1,221 |
11,179 |
10.9% |
1. The operating return is based upon group IFRS operating profit, which is stated before impairment of goodwill, amortisation of intangibles, exceptional items and investment variance.
2. The net internal debt loss before tax of £186million comprises investment return of £41 million offset by group internal debt costs and other interest of £227 million.
___________________
Page 75
C3 ii - Analysis of MCEV return on capital employed
|
30 June 2010 |
|||
|
Operating return1 |
|
Annualised |
|
|
Before tax |
After tax |
||
Life assurance |
|
|
|
|
United Kingdom |
559 |
402 |
5,797 |
13.9% |
France |
494 |
325 |
3,093 |
21.0% |
Ireland |
41 |
36 |
1,340 |
5.4% |
Italy |
146 |
99 |
1,695 |
11.7% |
Poland |
99 |
80 |
1,312 |
12.2% |
Spain |
95 |
66 |
1,950 |
6.8% |
Other Europe |
18 |
14 |
348 |
8.0% |
Aviva Europe |
893 |
620 |
9,738 |
12.7% |
Delta Lloyd |
157 |
116 |
2,835 |
8.2% |
Europe |
1,050 |
736 |
12,573 |
11.7% |
North America |
271 |
176 |
1,582 |
22.3% |
Asia Pacific |
38 |
30 |
741 |
8.1% |
|
1,918 |
1,344 |
20,693 |
13.0% |
General insurance and health |
|
|
|
|
United Kingdom3 |
223 |
161 |
1,876 |
17.2% |
France |
11 |
7 |
410 |
3.4% |
Ireland |
24 |
22 |
450 |
9.8% |
Other Europe |
11 |
8 |
329 |
4.9% |
Aviva Europe |
46 |
37 |
1,189 |
6.2% |
Delta Lloyd |
81 |
60 |
545 |
22.0% |
Europe |
127 |
97 |
1,734 |
11.2% |
North America |
132 |
90 |
928 |
19.4% |
Asia Pacific |
(2) |
(2) |
24 |
(16.7)% |
|
480 |
346 |
4,562 |
15.2% |
Fund management |
13 |
9 |
269 |
6.7% |
Other business |
(33) |
(24) |
(246) |
19.5% |
Corporate |
(103) |
(84) |
(34) |
494.1% |
Subordinated debt |
(146) |
(105) |
(4,637) |
4.5% |
External debt |
(22) |
(16) |
(852) |
3.8% |
Net internal debt2 |
(76) |
(55) |
(1,293) |
8.5% |
|
2,031 |
1,415 |
18,462 |
15.3% |
Less: Non-controlling interests |
|
(268) |
(4,237) |
12.7% |
Direct capital instrument |
|
- |
(990) |
- |
Preference capital |
|
(9) |
(200) |
9.0% |
Return on equity shareholders' funds |
|
1,138 |
13,035 |
17.5% |
1. The operating return is based upon group MCEV operating profit, which is stated before impairment of goodwill, amortisation of intangibles, exceptional items and investment variance.
2. The net internal debt loss before tax of £76 million comprises investment return of £45 million offset by group internal debt costs and other interest of £121 million.
3. Opening shareholders' funds includes the impact of allocating a share of the UK pension scheme deficit, which lowers shareholders' funds and increases annualised return on capital.
________________
Page 76
C3 ii - Analysis of MCEV return on capital employed continued
|
31 December 2009 |
|||
|
Operating return1 |
Restated |
Annualised |
|
|
Before tax |
After tax |
||
Life assurance |
|
|
|
|
United Kingdom |
787 |
567 |
5,069 |
11.2% |
France |
785 |
515 |
2,872 |
17.9% |
Ireland |
64 |
55 |
1,492 |
3.7% |
Italy |
216 |
147 |
1,671 |
8.8% |
Poland |
499 |
404 |
1,415 |
28.6% |
Spain |
113 |
79 |
2,189 |
3.6% |
Other Europe |
27 |
23 |
335 |
6.9% |
Aviva Europe |
1,704 |
1,223 |
9,974 |
12.3% |
Delta Lloyd |
531 |
388 |
2,666 |
14.6% |
Europe |
2,235 |
1,611 |
12,640 |
12.7% |
North America |
266 |
266 |
750 |
35.5% |
Asia Pacific |
101 |
71 |
981 |
7.2% |
|
3,389 |
2,515 |
19,440 |
12.9% |
General insurance and health |
|
|
|
|
United Kingdom3 |
494 |
356 |
2,592 |
13.7% |
France |
96 |
63 |
400 |
15.8% |
Ireland |
57 |
50 |
545 |
9.2% |
Other Europe |
(21) |
(15) |
377 |
(4.0)% |
Aviva Europe |
132 |
98 |
1,322 |
7.4% |
Delta Lloyd |
143 |
104 |
705 |
14.8% |
Europe |
275 |
202 |
2,027 |
10.0% |
North America |
144 |
98 |
878 |
11.2% |
Asia Pacific |
6 |
4 |
19 |
21.1% |
|
919 |
660 |
5,516 |
12.0% |
Fund management |
51 |
36 |
340 |
10.6% |
Other business |
(173) |
(121) |
(199) |
60.8% |
Corporate |
(182) |
(156) |
(30) |
520.0% |
Subordinated debt |
(293) |
(211) |
(4,606) |
4.6% |
External debt |
(42) |
(30) |
(919) |
3.3% |
Net internal debt2 |
(186) |
(134) |
(2,110) |
6.4% |
|
3,483 |
2,559 |
17,432 |
14.7% |
Less: Non-controlling interests |
|
(366) |
(3,080) |
11.9% |
Direct capital instrument |
|
(44) |
(990) |
4.4% |
Preference capital |
|
(17) |
(200) |
8.5% |
Return on equity shareholders' funds |
|
2,132 |
13,162 |
16.2% |
1. The operating return is based upon group MCEV operating profit, which is stated before impairment of goodwill, amortisation of intangibles, exceptional items and investment variance.
2. The net internal debt loss before tax of £186million comprises investment return of £41 million offset by group internal debt costs and other interest of £227 million.
3. Opening shareholders' funds includes the impact of allocating a share of the UK pension scheme deficit, which lowers shareholders' funds and increases annualised return on capital.
__________________
Page 77
C4 - Capital generation and utilisation
The active management of the generation and utilisation of capital is a primary Group focus, with the balancing of new business investment and shareholder distributions with operational capital generation a key financial priority. We announced in the first quarter IMS that we expect to generate approximately £1.3 billion of net operating capital in 2010, a 30% increase on 2009. The strong half year result of £0.9 billon reinforces our confidence in the capital generation position of the Group, and we are now revising our full year guidance to £1.5 billion.
The half year result of £0.9 billion represents a £0.4 billion improvement on the 30 June 2009 position. In-force profits from the life business remain strong, generating £1.1 billion of capital in the half year (6 months 2009: £1.1 billion), with a further £0.3 billion (6 months 2009: £0.3 billion) generated by the general insurance, fund management and non-insurance businesses. Capital invested in new business has reduced significantly to £0.5 billion (6 months 2009: £0.9 billion), benefiting in particular from management of volumes and other capital efficiency actions in the US business and the utilisation of the RIEESA to finance new business in UK Life.
|
6 months 2010 |
Full year 2009 |
6 months 2009 |
Operational capital generation: |
|
|
|
Life in-force profits |
1.1 |
1.9 |
1.1 |
General insurance, fund management and non-insurance profits |
0.3 |
0.6 |
0.3 |
Operational capital generated before investment in new business |
1.4 |
2.5 |
1.4 |
Capital invested in new business |
(0.5) |
(1.5) |
(0.9) |
Operational capital generated after investment in new business |
0.9 |
1.0 |
0.5 |
Operational capital generation comprises the following components:
- Free surplus emergence, including release of required capital, for the life in-force business (net of tax and minorities);
- IFRS operating profits for the general insurance and non-life businesses (net of tax and minorities);
- Capital invested in new business. For the life business this is the impact of initial and required capital on free surplus. For general insurance businesses this reflects the movement in required capital, which we have assumed to equal two times the regulatory minimum. Where appropriate, the movement in capital requirements excludes the impact of foreign exchange movements.
As well as financing new business investment, operational capital generated is used to finance corporate costs, service the Group's debt capital and to finance shareholder dividend distributions. After taking these items into account the net operational capital generated after financing remains at a £0.3 billion surplus, a strong improvement on the flat position in the 2009 half year. In addition to the underlying improvement in operational capital generation, the net position also benefits from the dividend re-basing undertaken with the 2009 interim dividend.
|
6 months 2010 |
Full year 2009 |
6 months 2009 |
Operational capital generated after investment in new business |
0.9 |
1.0 |
0.5 |
Interest, corporate and other costs |
(0.3) |
(0.5) |
(0.2) |
External dividend net of scrip |
(0.3) |
(0.6) |
(0.3) |
Net operational capital generation after financing |
0.3 |
(0.1) |
- |
_________________
Page 78
C5 - Capital required to write new business, internal rate of return and payback period
As set out above, the group generates a significant amount of capital each year. This capital generation supports both shareholder distribution and reinvestment in new business. The internal rates of return on new business written during the period are set out below.
6 months 2010 |
Initial |
Required |
Total invested |
IRR |
Payback period |
United Kingdom |
59 |
93 |
152 |
15% |
7 |
France |
27 |
95 |
122 |
9% |
11 |
Ireland |
23 |
11 |
34 |
6% |
10 |
Italy |
31 |
128 |
159 |
10% |
7 |
Poland |
7 |
4 |
11 |
25% |
4 |
Spain |
14 |
36 |
50 |
22% |
4 |
Other Europe |
21 |
7 |
28 |
17% |
5 |
Aviva Europe |
123 |
281 |
404 |
12% |
8 |
Delta Lloyd |
57 |
65 |
122 |
5% |
19 |
Europe |
180 |
346 |
526 |
10% |
10 |
North America |
54 |
178 |
232 |
14% |
4 |
Asia Pacific |
29 |
24 |
53 |
10% |
12 |
Total |
322 |
641 |
963 |
12.0% |
8 |
6 months 2009 |
Initial |
Required |
Total invested |
IRR |
|
United Kingdom |
77 |
59 |
136 |
13% |
|
France |
17 |
84 |
101 |
10% |
|
Ireland |
26 |
12 |
38 |
5% |
|
Italy |
14 |
93 |
107 |
10% |
|
Poland |
10 |
4 |
14 |
23% |
|
Spain |
13 |
41 |
54 |
27% |
|
Other Europe |
19 |
3 |
22 |
14% |
|
Aviva Europe |
99 |
237 |
336 |
13% |
|
Delta Lloyd |
59 |
51 |
110 |
5% |
|
Europe |
158 |
288 |
446 |
11% |
|
North America |
139 |
285 |
424 |
7% |
|
Asia Pacific |
32 |
30 |
62 |
7% |
|
Total |
406 |
662 |
1,068 |
9.5% |
|
Full year 2009 |
Initial |
Required |
Total invested |
IRR |
Payback period |
United Kingdom |
109 |
133 |
242 |
14% |
8 |
France |
53 |
169 |
222 |
9% |
9 |
Ireland |
56 |
23 |
79 |
6% |
10 |
Italy |
27 |
156 |
183 |
10% |
7 |
Poland |
20 |
9 |
29 |
22% |
5 |
Spain |
25 |
72 |
97 |
26% |
3 |
Other Europe |
43 |
7 |
50 |
12% |
8 |
Aviva Europe |
224 |
436 |
660 |
13% |
7 |
Delta Lloyd |
116 |
140 |
256 |
6% |
33 |
Europe |
340 |
576 |
916 |
11% |
15 |
North America |
162 |
376 |
538 |
7% |
14 |
Asia Pacific |
60 |
59 |
119 |
8% |
20 |
Total |
671 |
1,144 |
1,815 |
10.0% |
14 |
The capital invested data above is stated gross of non-controlling interests and valued on a point of sale basis. This differs from the analysis of life and pensions earnings in notes E7 and E8 which is stated net of minorities, valued on a year-end basis and benefits from the writing of new business in the UK Life RIEESA. The reconciliation is as follows:
6 months 2010 |
£m |
Total capital invested |
963 |
Non-controlling interests |
(193) |
Benefit of RIEESA on new business funding |
(73) |
Timing differences (point of sale versus year end basis) |
(29) |
New business impact on free surplus |
668 |
Individual regulated subsidiaries measure and report solvency based on applicable local regulations, including in the UK the regulations established by the Financial Services Authority (FSA). These measures are also consolidated under the European Insurance Groups Directive (IGD) to calculate regulatory capital adequacy at an aggregate group level, where we have a regulatory obligation to have a positive position at all times. This measure represents the excess of the aggregate value of regulatory capital employed in our business over the aggregate minimum solvency requirements imposed by local regulators, excluding the surplus held in the UK and Ireland with-profit life funds. The minimum solvency requirement for our European businesses is based on the Solvency 1 Directive. In broad terms, for EU operations, this is set at 4% and 1% of non-linked and unit-linked life reserves respectively and for our general insurance portfolio of business is the higher of 18% of gross premiums or 26% of gross claims, in both cases adjusted to reflect the level of reinsurance recoveries. For our major non-European businesses (the US, and Canada) a risk charge on assets and liabilities approach is used.
Regulatory capital - Group: European Insurance Groups Directive (IGD)
|
UK life |
Other |
30 June |
31 December |
Insurance Groups Directive (IGD) capital resources |
4.6 |
10.0 |
14.6 |
15.7 |
Less: capital resources requirement |
(4.6) |
(6.2) |
(10.8) |
(11.2) |
Insurance Group Directive (IGD) excess solvency |
- |
3.8 |
3.8 |
4.5 |
Cover over EU minimum (calculated excluding UK life funds) |
|
|
1.6 times |
1.7 times |
The EU Insurance Groups Directive (IGD) regulatory capital solvency surplus has decreased by £0.7 billion since 31 December 2009 to £3.8 billion. This decrease is driven by negative market movements, dividends and pension scheme funding offset by profits for the period.
The key movements over the period are set out in the following table:
|
£bn |
IGD solvency surplus at 31 December 2009 |
4.5 |
Dividends net of scrip |
(0.3) |
Operating profits net of other income and expenses |
0.5 |
Market movements including foreign exchange |
(0.4) |
Pension scheme funding |
(0.5) |
Estimated IGD solvency surplus at 30 June 2010 |
3.8 |
Market movements include the impact of equity, credit spread, interest rate and foreign exchange movements net of the effect of hedging instruments. The recently revised funding arrangement agreed with the trustees of our UK staff pension scheme has resulted in a one off decrease in our IGD of £0.5 billion.
Regulatory capital - Long-term businesses
For our non-participating worldwide life assurance businesses, our capital requirements, expressed as a percentage of the EU minimum, are set for each business unit as the higher of:
- The level of capital at which the local regulator is empowered to take action;
- The capital requirement of the business unit under the group's economic capital requirements; and,
- The target capital level of the business unit.
The required capital across our life businesses varies between 100% and 325% of EU minimum or equivalent. The weighted average level of required capital for our non-participating life business, expressed as a percentage of the EU minimum (or equivalent) solvency margin has decreased to 127% (31 December 2009: 130%).
These levels of required capital are used in the calculation of the group's embedded value to evaluate the cost of locked in capital. At 30 June 2010 the aggregate regulatory requirements based on the EU minimum test amounted to £6.4 billion (31 December 2009: £6.1 billion). At this date, the actual net worth held in our long-term business was £9.4 billion (31 December 2009: £9.8 billion) which represents 147% (31 December 2009: 159%) of these minimum requirements.
_______________________
Page 80
C6 - Regulatory capital continued
Regulatory capital - UK Life with-profits funds
The available capital of the with-profit funds is represented by the realistic inherited estate. The estate represents the assets of the long-term with-profit funds less the realistic liabilities for non-profit policies within the funds, less asset shares aggregated across the with-profit policies and any additional amounts expected at the valuation date to be paid to in-force policyholders in the future in respect of smoothing costs, guarantees and promises. Realistic balance sheet information is shown below for the three main UK with-profit funds: Old With-Profit Sub Fund (OWPSF), New With-Profit Sub Fund (NWPSF) and UK Life & Pensions (UKL&P). These realistic liabilities have been included within the long-term business provision and the liability for insurance and investment contracts on the consolidated IFRS balance sheet at 30 June 2010 and 31 December 2009.
|
|
30 June 2010 |
|
31 December 2009 |
||||
|
Estimated realistic assets |
Realistic liabilities1 |
Estimated realistic inherited estate2 |
Support arrangement5 |
Estimated risk capital margin3 |
Estimated |
|
Estimated excess |
NWPSF |
20.5 |
20.5 |
- |
1.2 |
(0.4) |
0.8 |
|
0.6 |
OWPSF |
3.0 |
2.7 |
0.3 |
- |
(0.1) |
0.2 |
|
0.1 |
UKL&P4 |
20.0 |
18.4 |
1.6 |
- |
(0.2) |
1.4 |
|
1.4 |
Aggregate |
43.5 |
41.6 |
1.9 |
1.2 |
(0.7) |
2.4 |
|
2.1 |
1. These realistic liabilities include the shareholders' share of future bonuses of £0.5 billion (31 December 2009: £0.6 billion). Realistic liabilities adjusted to eliminate the shareholders' share of future bonuses are £41.1billion (31 December 2009: £42.1 billion). These realistic liabilities make provision for guarantees, options and promises on a market consistent stochastic basis. The value of the provision included within realistic liabilities is £2.3billion, £0.3 billion and £3.3 billion for NWPSF, OWPSF and UKL&P respectively (31 December 2009: £2.2 billion, £0.3 billion and £3.1 billion).
2. Estimated realistic inherited estate at 31 December 2009 was £nil, £0.2 billion and £1.6 billion for NWPSF, OWPSF and UKL&P respectively.
3. The risk capital margin (RCM) is 4.5 times covered by the inherited estate (31 December 2009: 3.6 times).
4. The UKL&P fund includes the Provident Mutual (PM) fund which has realistic assets and liabilities of £1.7 billion and therefore does not contribute to the realistic inherited estate.
5. The support arrangement represents the reattributed estate of £1.2 billion at 30 June 2010 held within the non-profit fund with UKL&P included within the other UK Life operations.
Investment mix
The aggregate investment mix of the assets in the three main with-profit funds was:
|
30 June |
31 December 2009 |
Equity |
22% |
21% |
Property |
18% |
12% |
Fixed interest |
57% |
59% |
Other |
4% |
8% |
The equity backing ratios, including property, supporting with-profit asset shares are 66% in NWPSF and OWPSF, and 68% in UKL&P.
_________________
Page 81
C7 - IFRS Sensitivity analysis
The Group uses a number of sensitivity test-based risk management tools to understand the volatility of earnings, the volatility of its capital requirements, and to manage its capital more efficiently. Primarily, MCEV, ICA, and scenario analysis are used. Sensitivities to economic and operating experience are regularly produced on all of the Group's financial performance measurements to inform the Group's decision making and planning processes, and as part of the framework for identifying and quantifying the risks that each of its business units, and the Group as a whole are exposed to.
For long-term business in particular, sensitivities of MCEV performance indicators to changes in both economic and noneconomic experience are continually used to manage the business and to inform the decision making process. More information on MCEV sensitivities can be found in the presentation of results on an MCEV basis in the supplementary section of this report.
Life insurance and investment contracts
The nature of long-term business is such that a number of assumptions are made in compiling these financial statements. Assumptions are made about investment returns, expenses, mortality rates, and persistency in connection with the in-force policies for each business unit. Assumptions are best estimates based on historic and expected experience of the business. A number of the key assumptions for the Group's central scenario are disclosed elsewhere in these statements for both IFRS reporting and reporting under MCEV methodology.
General insurance and health business
General insurance and health claim liabilities are estimated by using standard actuarial claims projection techniques.
These methods extrapolate the claims development for each accident year based on the observed development of earlier years. In most cases, no explicit assumptions are made as projections are based on assumptions implicit in the historic claims.
Sensitivity test results
Illustrative results of sensitivity testing for long-term business, general insurance and health business and the fund management and non-insurance business are set out below. For each sensitivity test the impact of a reasonably possible change in a single factor is shown, with other assumptions left unchanged.
Sensitivity factor |
Description of sensitivity factor applied |
Interest rate and investment return |
The impact of a change in market interest rates by a 1% increase or decrease. The test allows consistently for similar changes to investment returns and movements in the market value of backing fixed interest securities. |
Equity/property market values |
The impact of a change in equity/property market values by ± 10%. |
Expenses |
The impact of an increase in maintenance expenses by 10%. |
Assurance mortality/morbidity |
The impact of an increase in mortality/morbidity rates for assurance contracts by 5%. |
Annuitant mortality |
The impact of a reduction in mortality rates for annuity contracts by 5%. |
Gross loss ratios |
The impact of an increase in gross loss ratios for general insurance and health business by 5%. |
__________________
Page 82
C7 - IFRS Sensitivity analysis continued
Long-term businesses
|
30 June 2010 |
||||||
Impact on profit before tax |
Interest rates |
Interest rates |
Equity/ property |
Equity/ property |
Expenses |
Assurance mortality |
Annuitant mortality |
Insurance participating |
(45) |
(360) |
45 |
(55) |
(30) |
(5) |
- |
Insurance non-participating |
(80) |
85 |
80 |
(65) |
(20) |
(40) |
(300) |
Investment participating |
(25) |
(5) |
35 |
(30) |
(15) |
- |
- |
Investment non-participating |
(25) |
35 |
20 |
(20) |
(5) |
- |
- |
Assets backing life shareholders' funds |
- |
- |
150 |
(145) |
- |
- |
- |
Total |
(175) |
(245) |
330 |
(315) |
(70) |
(45) |
(300) |
|
30 June 2010 |
||||||
Impact on shareholders' equity before tax |
Interest rates |
Interest rates |
Equity/ property |
Equity/ property |
Expenses |
Assurance mortality |
Annuitant mortality |
Insurance participating |
(75) |
(320) |
45 |
(60) |
(30) |
(5) |
- |
Insurance non-participating |
(440) |
475 |
205 |
(190) |
(20) |
(40) |
(300) |
Investment participating |
(25) |
(5) |
35 |
(30) |
(15) |
- |
- |
Investment non-participating |
(105) |
125 |
20 |
(20) |
(5) |
- |
- |
Assets backing life shareholders' funds |
(95) |
95 |
260 |
(255) |
- |
- |
- |
Total |
(740) |
370 |
565 |
(555) |
(70) |
(45) |
(300) |
|
31 December 2009 |
||||||
Impact on profit before tax |
Interest rates |
Interest rates |
Equity/ property |
Equity/ property |
Expenses |
Assurance mortality |
Annuitant mortality |
Insurance participating |
(20) |
(275) |
15 |
(35) |
(15) |
(5) |
(40) |
Insurance non-participating |
(190) |
270 |
35 |
(35) |
(25) |
(40) |
(280) |
Investment participating |
(65) |
(15) |
20 |
(30) |
(15) |
- |
- |
Investment non-participating |
(30) |
45 |
20 |
(20) |
(5) |
- |
- |
Assets backing life shareholders' funds |
(10) |
10 |
135 |
(140) |
- |
- |
- |
Total |
(315) |
35 |
225 |
(260) |
(60) |
(45) |
(320) |
|
31 December 2009 |
||||||
Impact on shareholders' equity before tax |
Interest rates |
Interest rates |
Equity/ property |
Equity/ property |
Expenses |
Assurance mortality |
Annuitant mortality |
Insurance participating |
(40) |
(235) |
20 |
(40) |
(15) |
(5) |
(40) |
Insurance non-participating |
(380) |
535 |
220 |
(220) |
(25) |
(40) |
(280) |
Investment participating |
(65) |
(15) |
20 |
(30) |
(15) |
- |
- |
Investment non-participating |
(80) |
125 |
20 |
(20) |
(5) |
- |
- |
Assets backing life shareholders' funds |
(65) |
85 |
215 |
(215) |
- |
- |
- |
Total |
(630) |
495 |
495 |
(525) |
(60) |
(45) |
(320) |
The different impacts of the economic sensitivities on profit and shareholders' equity arise from classification of certain assets as available for sale in some business units, for which movements in unrealised gains or losses would be taken directly to shareholders' equity.
The sensitivities to economic movements relate mainly to business in the UK, US and the Netherlands. In general a fall in market interest rates has a beneficial impact on non-participating business and shareholders' funds, due to the increase in market value of fixed interest securities and the relative durations of assets and liabilities; similarly a rise in interest rates has a negative impact. In the US most debt securities are classified as available-for-sale, which limits the overall sensitivity of IFRS profit to interest rate movements. The sensitivity to movements in equity and property market values relates mainly to holdings in the Netherlands, although the impact on IFRS profit is moderated by the classification of equities as available for sale.
Changes in sensitivities between 31 December 2009 and 30 June 2010 reflect movements in market interest rates, portfolio growth, changes to asset mix and the relative durations of assets and liabilities and asset liability management actions.
The mortality sensitivities relate primarily to the UK.
_________________________
Page 83
C7 - IFRS Sensitivity analysis continued
General insurance and health businesses
|
30 June 2010 |
|||||
Impact on profit before tax |
Interest |
Interest |
Equity/ property |
Equity/ property |
Expenses |
Gross loss ratios |
Gross of reinsurance |
(290) |
270 |
90 |
(95) |
(80) |
(155) |
Net of reinsurance |
(350) |
350 |
90 |
(95) |
(80) |
(145) |
|
30 June 2010 |
|||||
Impact on shareholders' equity before tax |
Interest |
Interest |
Equity/ property |
Equity/ property |
Expenses |
Gross loss ratios |
Gross of reinsurance |
(290) |
270 |
90 |
(95) |
(35) |
(155) |
Net of reinsurance |
(350) |
350 |
90 |
(95) |
(35) |
(145) |
|
31 December 2009 |
|||||
Impact on profit before tax |
Interest |
Interest |
Equity/ property |
Equity/ property |
Expenses |
Gross loss ratios |
Gross of reinsurance |
(310) |
295 |
105 |
(110) |
(135) |
(345) |
Net of reinsurance |
(365) |
365 |
105 |
(110) |
(135) |
(330) |
|
31 December 2009 |
|||||
Impact on shareholders' equity before tax |
Interest |
Interest |
Equity/ property |
Equity/ property |
Expenses |
Gross loss ratios |
Gross of reinsurance |
(310) |
295 |
105 |
(110) |
(35) |
(345) |
Net of reinsurance |
(365) |
365 |
105 |
(110) |
(35) |
(330) |
For general insurance, the impact of the expense sensitivity on profit also includes the increase in ongoing administration expenses, in addition to the increase in the claims handling expense provision.
Fund management and non-insurance businesses
|
30 June 2010 |
|||
Impact on profit before tax |
Interest |
Interest |
Equity/ property |
Equity/ property |
Total |
40 |
10 |
40 |
20 |
|
30 June 2010 |
|||
Impact on shareholders' equity before tax |
Interest |
Interest |
Equity/ property |
Equity/ property |
Total |
(20) |
80 |
55 |
5 |
|
31 December 2009 |
|||
Impact on profit before tax |
Interest |
Interest |
Equity/ property |
Equity/ property |
Total |
(20) |
25 |
70 |
(30) |
|
31 December 2009 |
|||
Impact on shareholders' equity before tax |
Interest |
Interest |
Equity/ property |
Equity/ property |
Total |
(40) |
55 |
80 |
(50) |
The sensitivity of the Group's fund management and non-insurance business to movements in equity and property markets includes the impact of hedging instruments held at Group Centre.
_____________________
Page 84
C7 - IFRS Sensitivity analysis continued
Limitations of sensitivity analysis
The above tables demonstrate the effect of a change in a key assumption while other assumptions remain unchanged. In reality, there is correlation between the assumptions and other factors. It should also be noted that these sensitivities are non-linear, and larger or smaller impacts should not be interpolated or extrapolated from these results.
The sensitivity analyses do not take into consideration that the group's assets and liabilities are actively managed. Additionally, the financial position of the group may vary at the time that any actual market movement occurs. For example, our financial risk management strategy aims to manage the exposure to market fluctuations.
As investment markets move past various trigger levels, management actions could include selling investments, changing investment portfolio allocation, adjusting bonuses credited to policyholders, and taking other protective action.
A number of the business units use passive assumptions to calculate their long-term business liabilities. Consequently, the actual impact of a change in the assumptions may not have any impact on the liabilities, whereas assets are held at market value on the statement of financial position. In these circumstances, the different measurement bases for liabilities and assets may lead to volatility in shareholder equity. Similarly, for general insurance liabilities, the interest rate sensitivities only affect profit and equity where explicit assumptions are made regarding interest (discount) rates or future inflation.
Other limitations in the above sensitivity analyses include the use of hypothetical market movements to demonstrate potential risk that only represent the group's view of possible near-term market changes that cannot be predicted with any certainty; and the assumption that all interest rates move in an identical fashion.
_______________________
Page 85
Analysis of Assets
D1 |
Total assets - shareholder/policyholder exposure to risk |
86 |
D2 |
Total assets - valuation bases/fair value hierarchy |
87 |
D3 |
Analysis of asset quality |
|
|
D3.1 Loans |
90 |
|
D3.2 Financial investments |
94 |
D4 |
Pension fund assets |
97 |
D5 |
Available funds |
98 |
D6 |
Guarantees |
98 |
________________________
Page 86
As an insurance business, Aviva Group holds a variety of assets to match the characteristics and duration of its insurance liabilities. Appropriate and effective asset liability matching (on an economic basis) is the principal way in which we manage our investments. In addition, to support this, we also use a variety of hedging and other risk management strategies to diversify away residual mis-match risk that is outside of our risk appetite.
D1 - Total assets - Shareholder/policyholder exposure to risk
30 June 2010 |
Policyholder assets £m |
Participating fund assets £m |
Shareholder assets £m |
Total assets analysed £m |
Less £m |
Balance sheet total £m |
Goodwill and acquired value of in-force business and |
- |
- |
6,019 |
6,019 |
- |
6,019 |
Interests in joint ventures and associates |
253 |
612 |
2,274 |
3,139 |
- |
3,139 |
Property and equipment |
21 |
73 |
592 |
686 |
- |
686 |
Investment property |
3,543 |
6,899 |
2,100 |
12,542 |
(6) |
12,536 |
Loans |
1,746 |
7,701 |
31,947 |
41,394 |
- |
41,394 |
Financial investments |
|
|
|
|
|
|
Debt securities |
16,855 |
81,282 |
62,480 |
160,617 |
- |
160,617 |
Equity securities |
27,483 |
8,664 |
4,595 |
40,742 |
- |
40,742 |
Other investments |
23,820 |
8,785 |
2,618 |
35,223 |
- |
35,223 |
Reinsurance assets |
1,329 |
983 |
4,959 |
7,271 |
- |
7,271 |
Deferred tax assets |
- |
- |
288 |
288 |
- |
288 |
Current tax assets |
- |
- |
269 |
269 |
- |
269 |
Receivables and other financial assets |
138 |
2,209 |
6,694 |
9,041 |
- |
9,041 |
Deferred acquisition costs and other assets |
133 |
781 |
4,451 |
5,365 |
- |
5,365 |
Prepayments and accrued income |
96 |
1,282 |
2,198 |
3,576 |
- |
3,576 |
Cash and cash equivalents |
5,028 |
15,047 |
8,371 |
28,446 |
- |
28,446 |
Assets of operations classified as held for sale |
- |
- |
- |
- |
6 |
6 |
Total |
80,445 |
134,318 |
139,855 |
354,618 |
- |
354,618 |
Total % |
22.7% |
37.9% |
39.4% |
100.0% |
- |
100.0% |
FY09 (Restated) |
82,686 |
135,628 |
136,077 |
354,391 |
- |
354,391 |
FY09 % (Restated) |
23.3% |
38.3% |
38.4% |
100.0% |
- |
100.0% |
As at 30 June 2010, 39.4% of our total asset base was Shareholder assets, 37.9% Participating assets where Aviva shareholders have partial exposure, and 22.7% Policyholder assets where Aviva shareholders have no exposure. Of the total assets, investment property, loans and financial investments comprised £290,512 million, compared to £292,180 million at FY09. This reduction is primarily due to a weakening of the Euro exchange rate, partially offset by new assets invested in our U.S. and European operations due to business growth and significant strengthening of the U.S. dollar exchange rate.
During 2010, our Spanish business undertook a review of the allocation of assets between shareholder and policyholder funds. As a result, debt securities of £2,362 million and equity securities of £10 million previously recognised as participating fund assets were reclassified as shareholder assets.
___________________________
Page 87
D2 - Total assets - Valuation bases/fair value hierarchy
|
30 June 2010 |
|
|
|
31 December 2009 |
||||
Total assets |
Fair value £m |
Amortised cost £m |
Equity accounted /tax £m |
Total £m |
|
Fair value £m |
Amortised cost |
Equity accounted |
Total |
Goodwill and acquired value of in-force business and |
- |
6,019 |
- |
6,019 |
|
- |
6,241 |
- |
6,241 |
Interests in joint ventures and associates |
- |
- |
3,139 |
3,139 |
|
- |
- |
2,982 |
2,982 |
Property and equipment |
368 |
318 |
- |
686 |
|
415 |
340 |
- |
755 |
Investment property |
12,542 |
- |
- |
12,542 |
|
12,430 |
- |
- |
12,430 |
Loans |
20,996 |
20,398 |
- |
41,394 |
|
20,890 |
20,189 |
- |
41,079 |
Financial investments |
|
|
|
|
|
|
|
|
|
Debt securities |
160,617 |
- |
- |
160,617 |
|
160,510 |
- |
- |
160,510 |
Equity securities |
40,742 |
- |
- |
40,742 |
|
43,343 |
- |
- |
43,343 |
Other investments |
35,223 |
- |
- |
35,223 |
|
34,849 |
- |
- |
34,849 |
Reinsurance assets |
- |
7,271 |
- |
7,271 |
|
- |
7,572 |
- |
7,572 |
Deferred tax assets |
- |
- |
288 |
288 |
|
- |
- |
218 |
218 |
Current tax assets |
- |
- |
269 |
269 |
|
- |
- |
359 |
359 |
Receivables and other financial assets |
- |
9,041 |
- |
9,041 |
|
- |
9,652 |
- |
9,652 |
Deferred acquisition costs and other assets |
- |
5,365 |
- |
5,365 |
|
- |
5,621 |
- |
5,621 |
Prepayments and accrued income |
- |
3,576 |
- |
3,576 |
|
- |
3,604 |
- |
3,604 |
Cash and cash equivalents |
28,446 |
- |
- |
28,446 |
|
25,176 |
- |
- |
25,176 |
Total |
298,934 |
51,988 |
3,696 |
354,618 |
|
297,613 |
53,219 |
3,559 |
354,391 |
Total % |
84.3% |
14.7% |
1.0% |
100.0% |
|
84.0% |
15.0% |
1.0% |
100.0% |
1. Within the group's statement of financial position, assets are recognised for deferred tax and current tax. The valuation basis of these assets does not directly fall within any of the categories outlined above. As such, these assets have been reported together with equity accounted within the analysis of the group's assets.
__________________
Page 88
D2 - Total assets - Valuation bases/fair value hierarchy continued
Total assets - Policyholder assets 30 June 2010 |
Fair value £m |
Amortised cost £m |
Equity accounted/ tax assets1 £m |
Total £m |
Goodwill and acquired value of in-force business and intangible assets |
- |
- |
- |
- |
Interests in joint ventures and associates |
- |
- |
253 |
253 |
Property and equipment |
21 |
- |
- |
21 |
Investment property |
3,543 |
- |
- |
3,543 |
Loans |
684 |
1,062 |
- |
1,746 |
Financial investments |
|
|
|
|
Debt securities |
16,855 |
- |
- |
16,855 |
Equity securities |
27,483 |
- |
- |
27,483 |
Other investments |
23,820 |
- |
- |
23,820 |
Reinsurance assets |
- |
1,329 |
- |
1,329 |
Deferred tax assets |
- |
- |
- |
- |
Current tax assets |
- |
- |
- |
- |
Receivables and other financial assets |
- |
138 |
- |
138 |
Deferred acquisition costs and other assets |
- |
133 |
- |
133 |
Prepayments and accrued income |
- |
96 |
- |
96 |
Cash and cash equivalents |
5,028 |
- |
- |
5,028 |
Total |
77,434 |
2,758 |
253 |
80,445 |
Total % |
96.3% |
3.4% |
0.3% |
100.0% |
FY09 |
79,807 |
2,523 |
356 |
82,686 |
FY09 % |
96.5% |
3.1% |
0.4% |
100.0% |
1. Within the group's statement of financial position, assets are recognised for deferred tax and current tax. The valuation basis of these assets does not directly fall within any of the categories outlined above. As such, these assets have been reported together with equity accounted within the analysis of the group's assets.
Total assets - Participating fund assets 30 June 2010 |
Fair value £m |
Amortised cost £m |
Equity accounted/ tax assets1 £m |
Total £m |
Goodwill and acquired value of in-force business and intangible assets |
- |
- |
- |
- |
Interests in joint ventures and associates |
- |
- |
612 |
612 |
Property and equipment |
32 |
41 |
- |
73 |
Investment property |
6,899 |
- |
- |
6,899 |
Loans |
1,101 |
6,600 |
- |
7,701 |
Financial investments |
|
|
|
|
Debt securities |
81,282 |
- |
- |
81,282 |
Equity securities |
8,664 |
- |
- |
8,664 |
Other investments |
8,785 |
- |
- |
8,785 |
Reinsurance assets |
- |
983 |
- |
983 |
Deferred tax assets |
- |
- |
- |
- |
Current tax assets |
- |
- |
- |
- |
Receivables and other financial assets |
- |
2,209 |
- |
2,209 |
Deferred acquisition costs and other assets |
- |
781 |
- |
781 |
Prepayments and accrued income |
- |
1,282 |
- |
1,282 |
Cash and cash equivalents |
15,047 |
- |
- |
15,047 |
Total |
121,810 |
11,896 |
612 |
134,318 |
Total % |
90.7% |
8.9% |
0.4% |
100.0% |
FY09 (Restated) |
122,794 |
12,237 |
597 |
135,628 |
FY09 % (Restated) |
90.5% |
9.0% |
0.5% |
100.0% |
1. Within the group's statement of financial position, assets are recognised for deferred tax and current tax. The valuation basis of these assets does not directly fall within any of the categories outlined above. As such, these assets have been reported together with equity accounted within the analysis of the group's assets.
_____________________
Page 89
D2 - Total assets - Valuation bases/fair value hierarchy continued
Total assets - Shareholder assets 30 June 2010 |
Fair value £m |
Amortised cost £m |
Equity accounted/ tax assets1 £m |
Total £m |
Goodwill and acquired value of in-force business and intangible assets |
- |
6,019 |
- |
6,019 |
Interests in joint ventures and associates |
- |
- |
2,274 |
2,274 |
Property and equipment |
315 |
277 |
- |
592 |
Investment property |
2,100 |
- |
- |
2,100 |
Loans |
19,211 |
12,736 |
- |
31,947 |
Financial investments |
|
|
|
|
Debt securities |
62,480 |
- |
- |
62,480 |
Equity securities |
4,595 |
- |
- |
4,595 |
Other investments |
2,618 |
- |
- |
2,618 |
Reinsurance assets |
- |
4,959 |
- |
4,959 |
Deferred tax assets |
- |
- |
288 |
288 |
Current tax assets |
- |
- |
269 |
269 |
Receivables and other financial assets |
- |
6,694 |
- |
6,694 |
Deferred acquisition costs and other assets |
- |
4,451 |
- |
4,451 |
Prepayments and accrued income |
- |
2,198 |
- |
2,198 |
Cash and cash equivalents |
8,371 |
- |
- |
8,371 |
Total |
99,690 |
37,334 |
2,831 |
139,855 |
Total % |
71.3% |
26.7% |
2.0% |
100.0% |
FY09 (Restated) |
95,012 |
38,459 |
2,606 |
136,077 |
FY09 % (Restated) |
69.8% |
28.3% |
1.9% |
100.0% |
1. Within the group's statement of financial position, assets are recognised for deferred tax and current tax. The valuation basis of these assets does not directly fall within any of the categories outlined above. As such, these assets have been reported together with equity accounted within the analysis of the group's assets.
Financial instruments (including derivatives and loans)
The Group classifies its investments as either financial assets at fair value through profit or loss (FV) or financial assets available for sale (AFS). The classification depends on the purpose for which the investments were acquired, and is determined by local management at initial recognition. The FV category has two subcategories - those that meet the definition as being held for trading and those the Group chooses to designate as FV (referred to in this section as "other than trading").
In general, the FV category is used as, in most cases, our investment or risk management strategy is to manage our financial investments on a fair value basis. All securities in the FV category are classified as other than trading, except for non-hedge derivatives and a small amount of debt and equity securities, bought with the intention to resell in the short term, which are classified as trading. The AFS category is used where the relevant long-term business liability (including shareholders' funds) is passively managed.
Loans are carried at amortised cost, except for certain mortgage loans, where we have taken advantage of the fair value option under IAS 39 to present the mortgages, associated borrowings, other liabilities and derivative financial instruments at fair value, since they are managed together on a fair value basis. We believe this presentation provides more relevant information and eliminates any accounting mismatch that would otherwise arise from using different measurement bases for these four items.
Fair value hierarchy
To provide further information on the valuation techniques we use to measure assets carried at fair value, we have categorised the measurement basis for assets carried at fair value into a 'fair value hierarchy' in accordance with the valuation inputs and consistent with IFRS7 Financial Instruments: Disclosures.
- Inputs to Level 1 fair values are quoted prices (unadjusted) in active markets for identical assets.
- Inputs to Level 2 fair values are inputs other than quoted prices included within Level 1 that are observable for the asset, either directly or indirectly. If the asset has a specified (contractual) term, a Level 2 input must be observable for substantially the full term of the asset.
- Inputs to Level 3 fair values are unobservable inputs for the asset. Unobservable inputs may have been used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset at the measurement date (or market information for the inputs to any valuation models). As such, unobservable inputs reflect the assumptions the business unit considers that market participants would use in pricing the asset. Examples are certain private equity investments and private placements.
Fair values sourced from internal models are Level 2 only if substantially all the inputs are market observable. Otherwise fair values sourced from internal models are classified as Level 3.
_____________________
Page 90
D2 - Total assets - Valuation bases/fair value hierarchy continued
The table below presents an analysis of investments according to fair value hierarchy:
|
Fair value hierarchy |
|
|
|
|||
Total assets 30 June 2010 |
Level 1 £m |
Level 2 £m |
Level 3 £m |
Sub-total fair value £m |
Amortised cost £m |
Less: £m |
Balance sheet total £m |
Investment properties |
- |
12,542 |
- |
12,542 |
- |
(6) |
12,536 |
Loans |
- |
20,996 |
- |
20,996 |
20,398 |
- |
41,394 |
Debt securities |
112,032 |
39,425 |
9,160 |
160,617 |
- |
- |
160,617 |
Equity securities |
34,120 |
5,921 |
701 |
40,742 |
- |
- |
40,742 |
Other investments (including derivatives) |
28,806 |
3,998 |
2,419 |
35,223 |
- |
- |
35,223 |
Total |
174,958 |
82,882 |
12,280 |
270,120 |
20,398 |
(6) |
290,512 |
Total % |
60.3% |
28.5% |
4.2% |
93.0% |
7.0% |
- |
100.0% |
FY09 |
181,125 |
79,637 |
11,260 |
272,022 |
20,189 |
(31) |
292,180 |
FY09% |
62.0% |
27.2% |
3.9% |
93.1% |
6.9% |
- |
100.0% |
At 30 June 2010, there has been a small decrease to 60% (FY09: 62%) in the proportion of total financial investments, loans and investment properties classified as Level 1 in the fair value hierarchy. Level 2 financial investments, loans and investment properties have increased to 29% (FY09: 27%). At Level 3 (fair valued using models with significant unobservable market parameters) financial investments, loans and investment properties have remained constant at 4% (FY09: 4%).
D3 - Analysis of asset quality
D3.1 - Loans
The group loan portfolio is principally made up of:
- Policy loans which are generally collateralised by a lien or charge over the underlying policy;
- Loans and advances to banks, which primarily relate to loans of cash collateral received in stock lending transactions. These loans are fully collateralised by other securities;
- Mortgage loans collateralised by property assets; and
- Other loans, which include loans and advances to customers of our banking business, and to brokers and intermediaries.
Loans with fixed maturities, including policy loans, mortgage loans (at amortised cost) and loans and advances to banks, are recognised when cash is advanced to borrowers. These loans are carried at their unpaid principal balances and adjusted for amortisation of premium or discount, non-refundable loan fees and related direct costs. These amounts are deferred and amortised over the life of the loan as an adjustment to loan yield using the effective interest rate method.
For certain mortgage loans, the group has taken advantage of the revised fair value option under IAS 39 to present the mortgages, associated borrowings, other liabilities and derivative financial instruments at fair value, since they are managed together on a fair value basis. Due to the illiquid nature of these assets, where fair value accounting is applied, it is done so on a Level 2 basis.
Loans - Total assets |
United Kingdom |
Aviva Europe |
Delta Lloyd |
North America |
Asia |
Total |
Policy loans |
47 |
890 |
337 |
467 |
37 |
1,778 |
Loans and advances to banks |
4,138 |
- |
1,356 |
- |
- |
5,494 |
Mortgage loans |
15,856 |
4 |
12,723 |
1,801 |
- |
30,384 |
Other loans |
37 |
15 |
3,599 |
85 |
2 |
3,738 |
Total |
20,078 |
909 |
18,015 |
2,353 |
39 |
41,394 |
Total % |
48.5% |
2.2% |
43.5% |
5.7% |
0.1% |
100.0% |
FY09 |
19,077 |
993 |
18,797 |
2,177 |
35 |
41,079 |
FY09% |
46.5% |
2.4% |
45.8% |
5.3% |
- |
100.0% |
Loans - Total shareholder assets |
United Kingdom |
Aviva Europe |
Delta Lloyd |
North America |
Asia |
Total |
Policy loans |
7 |
12 |
242 |
243 |
15 |
519 |
Loans and advances to banks |
267 |
- |
89 |
- |
- |
356 |
Mortgage loans |
14,079 |
- |
12,191 |
1,784 |
- |
28,054 |
Other loans |
37 |
4 |
2,890 |
85 |
2 |
3,018 |
Total |
14,390 |
16 |
15,412 |
2,112 |
17 |
31,947 |
Total % |
45.0% |
0.1% |
48.2% |
6.6% |
0.1% |
100.0% |
FY09 |
13,994 |
19 |
16,088 |
1,953 |
14 |
32,068 |
FY09% |
43.7% |
- |
50.2% |
6.1% |
- |
100.0% |
___________________
Page 91
D3 - Analysis of asset quality continued
D3.1 - Loans continued
The value of the group's loan portfolio at 30 June 2010 stood at £41,394 million (FY09: £41,079 million), an increase of £315 million, primarily due to an increase in loans and advances to banks in our UK Life business and an increase in mortgage sales in our Delta Lloyd business, offset by a weakening of the Euro exchange rate. This increase reflects a rise in the value of cash collateral we receive (and subsequently loan out) in our securities financing business due to the strengthening of the U.S. dollar exchange rate, market improvements and also reflects a rise in the level of business with cash counterparties.
Shareholder asset loans represented 77% of the total loan portfolio, with the remaining 23% in Participating funds (£7,701 million) and policyholder assets (£1,746 million).
The total shareholder asset exposure to loans has remained relatively stable at £31,947 million (FY09: £32,068 million). The marginal decrease has been primarily due to a weakening of the Euro exchange rate, partially offset by increases in the loans and advances to banks as explained above and a strengthening of the U.S. dollar exchange rate.
Mortgage loans - Shareholder assets
30 June 2010 |
United Kingdom |
Aviva Europe |
Delta Lloyd |
North America |
Asia |
Total |
Non-securitised mortgage loans |
|
|
|
|
|
|
- Residential |
- |
- |
5,357 |
- |
- |
5,357 |
- Equity release |
1,018 |
- |
- |
- |
- |
1,018 |
- Commercial |
8,494 |
- |
21 |
1,784 |
- |
10,299 |
- Healthcare |
2,673 |
- |
- |
- |
- |
2,673 |
|
12,185 |
- |
5,378 |
1,784 |
- |
19,347 |
Securitised mortgage loans |
1,894 |
- |
6,813 |
- |
- |
8,707 |
Total |
14,079 |
- |
12,191 |
1,784 |
- |
28,054 |
FY09 |
13,828 |
1 |
12,730 |
1,645 |
- |
28,204 |
Of the group's total loan portfolio (including Policyholder, Participating Fund and Shareholder assets), 73% (FY09: 74%) is invested in mortgage loans. The group's mortgage loan portfolio spans several business units, primarily UK, Delta Lloyd and USA, and across various sectors, including residential loans, commercial loans and government supported healthcare loans. Aviva shareholders are exposed predominantly to mortgage loans (accounting for 88% of total Shareholder asset loans). This section focuses on explaining the residual shareholder risk within these exposures.
Mortgage loan assets are divided into type of loan (residential, equity release, commercial, healthcare and securitised) and the regions in which they are held (predominantly United Kingdom, Netherlands (Delta Lloyd) and the United States). Each loan type and region has its own unique characteristic and composition.
Non-securitised mortgage loans - Residential
Delta Lloyd
Gross exposure by loan to value and arrears
30 June 2010 |
>120% |
115-120% |
110- 115% |
105- 110% |
100- 105% |
95- |
90- |
80- |
70- |
<70% |
Total |
Exposures by mortgage type |
|
|
|
|
|
|
|
|
|
|
|
- Government guaranteed |
882 |
184 |
149 |
117 |
104 |
95 |
78 |
110 |
69 |
156 |
1,944 |
- Non-government guaranteed |
258 |
91 |
84 |
213 |
172 |
629 |
248 |
421 |
442 |
855 |
3,413 |
Total |
1,140 |
275 |
233 |
330 |
276 |
724 |
326 |
531 |
511 |
1,011 |
5,357 |
Exposures by interest payment arrears |
|
|
|
|
|
|
|
|
|
|
|
Neither past due nor impaired |
1,088 |
263 |
226 |
315 |
265 |
698 |
317 |
513 |
500 |
985 |
5,170 |
0 - 3 months |
46 |
11 |
6 |
13 |
9 |
22 |
8 |
15 |
10 |
20 |
161 |
3 - 6 months |
4 |
- |
1 |
- |
1 |
2 |
- |
1 |
1 |
1 |
11 |
6 - 12 months |
2 |
- |
- |
1 |
- |
- |
- |
1 |
- |
3 |
7 |
> 12 months |
- |
- |
- |
1 |
1 |
2 |
1 |
1 |
- |
2 |
8 |
Total |
1,140 |
275 |
233 |
330 |
276 |
724 |
326 |
531 |
511 |
1,011 |
5,357 |
The total exposure to non-securitised mortgage loans in the Netherlands is £5,357 million, of which the majority are measured at amortised cost. However, of these, £1,944 million are Government guaranteed, and so present minimal risk to Aviva shareholders.
________________________
Page 92
D3 - Analysis of asset quality continued
D3.1 - Loans continued
The Government guarantees were introduced in the Netherlands to encourage homeownership, and apply to home mortgages of up to €350,000 (this threshold was raised from €265,000 at 1 July 2009). The guarantees are implemented through the National Mortgage Guarantee Scheme, and ensure that, should the homeowner be forced to sell, and cannot make the repayment on the mortgage, then the residual will be provided for by the Homeownership Guarantee Fund, which in turn is funded by the Government and municipalities through agreements for interest free loans.
In addition to government guarantees, the Dutch residential mortgage market also benefits from the ability for borrowers to deduct mortgage interest payments for tax purposes, thereby helping to reduce the risk of arrears or default.
The total amount of loans for which interest payments are past due is £186 million (FY09: £134 million). However, the actual amount of missed payments is £1.7 million (FY09: £2.7 million). Delta Lloyd has currently not made any additional provisions for these loans as it does not consider the amount of potential loss to be significant.
UK Residential
The UK non-securitised residential mortgage portfolio has a total current value of £1,018 million (FY09: £929 million). These mortgages are all in the form of equity release, whereby homeowners that usually own a fully paid up property will mortgage it to release cash equity. Due to the low relative levels of equity released in each property, they all currently have a Loan to Value ("LTV") of below 70%, and the average LTV across the portfolio is approximately 31%. We therefore consider these mortgages to be low risk.
Non-securitised mortgage loans - Commercial
Gross exposure by loan to value and arrears
United Kingdom
30 June 2010 |
>120% |
115- 120% |
110- 115% |
105- 110% |
100- 105% |
95- |
90- |
80- |
70- |
<70% |
Total |
Neither past due nor impaired |
529 |
879 |
665 |
1,224 |
571 |
496 |
800 |
1,647 |
889 |
456 |
8,156 |
0 - 3 months |
50 |
- |
- |
- |
- |
- |
- |
- |
- |
2 |
52 |
3 - 6 months |
37 |
- |
91 |
46 |
- |
- |
- |
- |
- |
2 |
176 |
6 - 12 months |
13 |
5 |
- |
- |
- |
43 |
- |
- |
- |
- |
61 |
> 12 months |
- |
- |
38 |
- |
- |
11 |
- |
- |
- |
- |
49 |
Total |
629 |
884 |
794 |
1,270 |
571 |
550 |
800 |
1,647 |
889 |
460 |
8,494 |
Of the £8,494 million of UK Commercial loans, £7,969 million are held by Aviva UK Life to back annuity liabilities, and are stated on a fair value basis. The loan exposures for the UK Life business are calculated on a discounted cash flow basis, and include a risk adjustment through the use of Credit Risk Adjusted Value ("CRAV") methods. The remaining £525 million of loans are held by Aviva UK General Insurance and are stated on an amortised cost basis. For the UK General Insurance business, mortgages are held at amortised cost, and subject to impairment review, using a fair value methodology calibrated to the UK Life approach, adjusted for specific portfolio characteristics.
The UK portfolio has maintained a strong track record notwithstanding the downturn in the property market. It has continued to provide strong income receipts to back payments to annuitants and maintained low levels of losses since 1993.
Mortgage LTV's increased slightly over the first half of 2010 resulting in the amount of exposure uncovered by the underlying security rising to £496m. The increased LTV levels result from falling gilt yields which have increased the fair value of the loans and enhancements made to the valuation methodology for the underlying properties. However, this change has had no impact on income cover levels which remain the primary risk driver within the mortgage portfolio.
All loans in arrears have been assessed for impairment. Of the £338 million (FY09: £357 million) value of loans in arrears, the interest and capital amount in arrears is only £11 million. The valuation allowance we made in the UK for short term defaults on corporate bonds and commercial mortgages carried at fair value remains unchanged. Together with our long-term default assumptions, this equates to a valuation allowance of £1.1 billion for the life of the UK Life corporate bond and commercial mortgage portfolio, and creates a strong buffer against potential future losses. In addition, we hold £65 million of provisions in our UK General Insurance mortgage portfolio, which is carried at amortised cost.
Loan service collection ratios remain resilient reflecting the strong rent collection reported by our borrowers. Loan Interest Cover ("LIC"), which is defined as the annual net rental income (including rental deposits and less ground rent) divided by the annual loan interest service, has remained stable at 1.3x due to low levels of material tenant defaults.
________________________
Page 93
D3 - Analysis of asset quality continued
D3.1 - Loans continued
The UK portfolio remains well diversified in terms of property type, location and tenants as well as the spread of loans written over time. The risks in commercial mortgages are addressed through several layers of protection with the mortgage risk profile being primarily driven by the ability of the underlying tenant rental income to cover loan interest and amortisation. Should any single tenant default on their rental payment, rental from other tenants backing the same loan often ensures the loan interest cover does not fall below 1.0x. Where there are multiple loans to a single borrower further protection may be achieved through cross-charging where loans to a single borrower may be pooled so that any single loan is also supported by payments on the other pool loans. Additionally, there may be support provided by the borrower of the loan itself and further loss mitigation from the general floating charges held over other assets within the borrower companies.
If the LIC cover falls below 1.0x and the borrower defaults then Aviva still retains the option of selling the security or restructuring the loans and benefiting from the protection of the collateral. A combination of these benefits and the high recovery levels afforded by property collateral (compared to corporate debt or other uncollateralised credit exposures) results in the economic exposure being significantly lower than the gross exposure reported above.
UK Healthcare
Of the total UK non-securitised mortgage loans of £12,185 million (FY09: £11,988 million), £2,673 million (FY09: £2,537 million) relates to healthcare businesses and is secured against General Practitioner premises or other health related premises leased to NHS trusts or Primary Care Trusts. For all such loans, Government support is provided through reimbursement of rental payments to the tenants to meet income service and provide for the debt to be reduced substantially over the term of the loan. Although the loan principal is not Government guaranteed, the nature of these businesses and premises provides considerable comfort of an ongoing business model and low risk of default.
On a market value basis, we estimate the average LTV of these mortgages to be 100%, although as explained above, we do not consider this to be a key risk driver. Income support from the National Health Service and stability of the sector provide sustained income stability. Aviva therefore considers these loans to be low risk and uncorrelated with the strength of the UK or global economy.
North America
30 June 2010 |
>120% |
115- 120% |
110- 115% |
105- 110% |
100- 105% |
95- |
90- |
80- |
70- |
<70% |
Total |
Neither past due nor impaired |
25 |
5 |
26 |
9 |
41 |
63 |
86 |
226 |
320 |
976 |
1,775 |
0 - 3 months |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
3 - 6 months |
9 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
9 |
6 - 12 months |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
> 12 months |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Total |
33 |
5 |
26 |
9 |
41 |
63 |
86 |
226 |
320 |
976 |
1,784 |
Total % |
1.9% |
0.3% |
1.4% |
0.5% |
2.3% |
3.5% |
4.8% |
12.7% |
17.9% |
54.7% |
100.0% |
Aviva USA currently holds £1,784 million (FY09: £1,645 million) of commercial mortgages under Shareholder Assets. Of these,
55% (FY09: 51%) have LTV ratios of below 70%, and 85% (FY09: 85%) have LTV ratios of below 90%. However, the mortgage portfolio does currently have a total of £114 million (6% of portfolio) in principal balances where the LTV exceeds 100%. Although property prices in the U.S. have decreased, the mortgages continue to perform well, reflecting:
- low underwriting LTVs (shall not exceed 80% at the time of issuance), and consequently a portfolio with an average LTV of
67% (FY09: 68%);
- A highly diversified portfolio, with strong volumes in many states with more stable economies and related real estate values; and
- Strong LIC ratios, with 92% of the loans having an LIC above 1.4x, and less than 3% with LIC below 1.0x.
- As at 30 June 2010, only £9 million of loans were in arrears, although the amount of payments in arrears was only £0.5 million.
Securitised mortgage loans
Of the total securitised residential mortgages (£8,707 million), approximately £1.2 billion of securities are still held by Aviva. The remaining securities have been sold to third parties, and therefore present little credit risk to Aviva.
Securitised residential mortgages held are predominantly issued through vehicles in the Delta Lloyd and in the UK.
___________________
Page 94
D3 - Analysis of asset quality continued
D3.2 - Financial investments
Total Assets |
30 June 2010 |
|
31 December 2009 |
||||||
|
Cost/ |
Unrealised |
Impairment |
Fair value |
|
Cost/ |
Unrealised |
Impairment and |
Fair value |
Debt securities |
155,756 |
8,866 |
(4,005) |
160,617 |
|
159,287 |
5,872 |
(4,649) |
160,510 |
Equity securities |
42,683 |
3,412 |
(5,353) |
40,742 |
|
44,188 |
4,173 |
(5,018) |
43,343 |
Other investments |
34,221 |
1,785 |
(783) |
35,223 |
|
34,081 |
1,940 |
(1,172) |
34,849 |
Total |
232,660 |
14,063 |
(10,141) |
236,583 |
|
237,556 |
11,985 |
(10,839) |
238,702 |
The table above is a summary of the cost/amortised cost, gross unrealised gains and losses and fair value of financial investments.
Aviva holds large quantities of high quality bonds, primarily to match our liability to make guaranteed payments to policyholders. Some credit risk is taken, partly to increase returns to policyholders and partly to optimise the risk/return profile for shareholders. The risks are consistent with the products we offer and the related investment mandates, and are in line with our risk appetite.
The group also holds significant quantities of equities. The majority of these are held in participating funds or unit linked funds, where they form an integral part of the investment expectations of policyholders and follow well-defined investment mandates. Some equities are also held in shareholder funds and the staff pension schemes, where the holdings are designed to maximise long-term returns with an acceptable level of risk. The vast majority of equity investments are valued at quoted market prices.
D3.2.1 - Debt securities
|
|
|
|
30 June 2010 |
|
Fair value hierarchy |
|
||
Debt securities - Shareholder assets |
Level 1 £m |
Level 2 £m |
Level 3 £m |
Total £m |
UK Government |
1,702 |
- |
- |
1,702 |
Non-UK Government |
|
|
|
|
Europe |
10,290 |
262 |
15 |
10,567 |
North America |
267 |
2,991 |
124 |
3,382 |
Asia Pacific & Other |
1,351 |
188 |
92 |
1,631 |
Corporate bonds - Public utilities |
1,967 |
2,554 |
46 |
4,567 |
Corporate convertible bonds |
7 |
248 |
- |
255 |
Other corporate bonds |
11,623 |
19,875 |
757 |
32,255 |
Other |
2,247 |
5,506 |
368 |
8,121 |
Total |
29,454 |
31,624 |
1,402 |
62,480 |
Total % |
47.2% |
50.6% |
2.2% |
100.0% |
FY09 (Restated) |
29,818 |
27,208 |
1,786 |
58,812 |
FY09 % (Restated) |
50.7% |
46.3% |
3.0% |
100.0% |
Only 2.2% of shareholder exposure to debt securities (1.4% of shareholder assets recorded at fair value) are fair valued using models with significant unobservable market parameters (classified as Fair Value Level 3). Where estimates are used, these are based on a combination of independent third party evidence and internally developed models, calibrated to market observable data where possible.
47.2% of shareholder exposure to debt securities is based on quoted prices in an active market (classified as Fair Value Level 1; FY09: 50.7%). The decrease in the proportion of assets classified as Fair Value Level 1 (and corresponding increase in proportion of assets classified as Fair Value Level 2) predominantly reflects a rise in asset values in our U.S. business as a result of the strengthening of the U.S. dollar and an increase in invested assets due to business growth. The majority of the debt instruments held by our North American businesses are valued by independent pricing firms in accordance with usual market practice in that region and consistent with other companies operating in the region are classified as Level 2 in the Fair Value hierarchy. Excluding our North American businesses, the proportion of shareholder debt securities classified as Level 1 in the Fair Value hierarchy would be 88% (FY09: 88%).
__________________________
Page 96
D3 - Analysis of asset quality continued
D3.2.1 - Debt securities continued
|
|
|
|
|
Ratings |
|
|
Debt securities - Shareholder assets 30 June 2010 |
AAA £m |
AA £m |
A £m |
BBB £m |
Less than BBB £m |
Non-rated £m |
Total £m |
Government |
|
|
|
|
|
|
|
UK Government |
1,628 |
61 |
- |
- |
- |
- |
1,689 |
UK local authorities |
- |
13 |
- |
- |
- |
- |
13 |
Non-UK Government |
9,374 |
3,795 |
1,481 |
133 |
186 |
611 |
15,580 |
|
11,002 |
3,869 |
1,481 |
133 |
186 |
611 |
17,282 |
Corporate |
|
|
|
|
|
|
|
Public utilities |
70 |
242 |
2,491 |
1,535 |
59 |
170 |
4,567 |
Convertibles and bonds with warrants |
1 |
- |
115 |
77 |
24 |
38 |
255 |
Other corporate bonds |
2,981 |
4,915 |
11,098 |
9,817 |
1,452 |
1,992 |
32,255 |
|
3,052 |
5,157 |
13,704 |
11,429 |
1,535 |
2,200 |
37,077 |
Certificates of deposits |
- |
185 |
94 |
211 |
- |
12 |
502 |
Structured |
|
|
|
|
|
|
|
RMBS non-agency sub-prime |
- |
- |
- |
- |
- |
- |
- |
RMBS non-agency ALT A |
23 |
11 |
17 |
13 |
115 |
- |
179 |
RMBS non-agency prime |
366 |
82 |
35 |
59 |
30 |
- |
572 |
RMBS agency |
1,945 |
- |
- |
- |
- |
1 |
1,946 |
|
2,334 |
93 |
52 |
72 |
145 |
1 |
2,697 |
CMBS |
1,310 |
229 |
278 |
104 |
103 |
- |
2,024 |
ABS |
1,039 |
182 |
181 |
87 |
20 |
222 |
1,731 |
CDO (including CLO) |
44 |
50 |
22 |
22 |
76 |
52 |
266 |
ABCP |
- |
- |
- |
- |
- |
- |
- |
ABFRN |
- |
- |
- |
- |
- |
- |
- |
|
2,393 |
461 |
481 |
213 |
199 |
274 |
4,021 |
Wrapped credit |
63 |
109 |
63 |
117 |
29 |
35 |
416 |
Other |
12 |
4 |
215 |
5 |
3 |
246 |
485 |
Total |
18,856 |
9,878 |
16,090 |
12,180 |
2,097 |
3,379 |
62,480 |
Total% |
30.3% |
15.8% |
25.7% |
19.5% |
3.3% |
5.4% |
100.0% |
FY09 (Restated) |
19,531 |
8,451 |
15,211 |
10,824 |
1,714 |
3,081 |
58,812 |
FY09 % (Restated) |
33.2% |
14.4% |
25.9% |
18.4% |
2.9% |
5.2% |
100.0% |
The overall quality of the book remains strong, despite the continuing downgrade activity by the major rating agencies during the first half of 2010. 28% of shareholder exposure to debt securities is in government holdings (FY09: 29%). This slight reduction is primarily driven by strengthening of the U.S. dollar (resulting in an increase in the Sterling value of our U.S. operation's corporate holdings), and business growth in the U.S. operation in addition to changes in asset allocation within our Group Centre funds from UK Government debt to corporate debt. Our corporate debt securities portfolio represents 59% (FY09: 54%) of total debt securities and has increased since FY09 due to the factors above.
There has been some overall credit quality deterioration in our debt securities portfolio primarily due to the impact of the changes detailed above, as our corporate debt securities are in general rated lower than our government debt securities. There has been a negligible impact on our debt securities portfolio from the downgrade of various European governments during the first half of 2010 due to our active steps to reduce our exposure to the affected countries.
Our shareholder exposure to debt securities of £62,480 million includes £538 million of exposures to the governments (and local authorities and agencies) of Greece, Spain and Portugal. This represents just 0.2% of total balance sheet assets at 30 June 2010. A further £1,433 million of exposures to these governments are held in participating fund assets, although we have limited shareholder risk to these assets. Net of non-controlling interests, our total exposure to these governments is further reduced to £362 million within shareholder assets and £1,070 million within participating fund assets.
______________________
Page 96
D3 - Analysis of asset quality continued
D3.2 - Financial investments continued
The majority of the Residential Mortgage-Backed Securities (RMBS) are U.S. investments and over 70% of the shareholder exposure is backed by one of the U.S. Government Sponsored Entities (GSEs) including Fannie Mae and Freddie Mac which, under the conservatorship arrangements implemented in September 2008, are now backed by the full faith and credit of the U.S. Government. The majority of the remaining U.S. RMBS is backed by fixed rate loans originated in 2005 or before.
The Group has extremely limited exposure to 'Sub-prime' debt securities and also limited exposure to CDOs and CLOs.
The majority of the corporate bonds that are not rated represent private placements. The private placements are U.S. investments which are not rated by the major rating agencies but which are rated an average equivalent of between A and BBB by the Securities Valuation Office of the National Association of Insurance Commissioners (NAIC), a U.S. national regulatory agency.
Excluding the private placements that are rated by the NAIC, the exposure that is not rated by a major rating agency reduces to less than 2.0% of debt securities to which the shareholder has exposure.
D3.2.2 - Equity securities
|
30 June 2010 |
|
31 December 2009 (Restated) |
||||||
|
Fair value hierarchy |
|
|
Fair value hierarchy |
|
||||
Equity securities - Shareholder assets |
Level 1 £m |
Level 2 £m |
Level 3 £m |
Total £m |
|
Level 1 £m |
Level 2 £m |
Level 3 £m |
Total £m |
Public utilities |
9 |
- |
- |
9 |
|
12 |
14 |
- |
26 |
Banks, trusts and insurance companies |
748 |
298 |
652 |
1,698 |
|
1,154 |
299 |
295 |
1,748 |
Industrial miscellaneous and all other |
1,341 |
1,024 |
29 |
2,394 |
|
1,753 |
982 |
318 |
3,053 |
Non-redeemable preferred shares |
4 |
486 |
4 |
494 |
|
2 |
204 |
4 |
210 |
Total |
2,102 |
1,808 |
685 |
4,595 |
|
2,921 |
1,499 |
617 |
5,037 |
Total % |
45.7% |
39.4% |
14.9% |
100.0% |
|
58.0% |
29.8% |
12.2% |
100.0% |
Over 45% of our shareholder exposure to equity securities is based on quoted prices in an active market and as such is classified as Level 1 (FY09: 58%). The reduction since FY09 has primarily been a result of the transfer of some strategic equity holdings to our staff pension fund, dilution of shareholdings due to not subscribing to rights issues and a weakening in the Euro exchange rate. Continued reduced liquidity in equity markets during the first half of 2010 means that there continues to be a proportion of equities classified as Level 3 (values based on quoted prices in markets that are not active or where the prices are less current).
Shareholder investments include a strategic holding in Unicredit and other Italian banks of £467 million (£309 million net of non-controlling interest share).
D3.2.3 - Other investments
|
30 June 2010 |
|
31 December 2009 |
||||||
|
Fair value hierarchy |
|
|
Fair value hierarchy |
|
||||
Other investments - Shareholder assets |
Level 1 £m |
Level 2 £m |
Level 3 £m |
Total £m |
|
Level 1 £m |
Level 2 £m |
Level 3 £m |
Total £m |
Unit trusts and other investment vehicles |
466 |
34 |
46 |
546 |
|
467 |
148 |
- |
615 |
Derivative financial instruments |
123 |
1,312 |
13 |
1,448 |
|
76 |
1,221 |
14 |
1,311 |
Deposits with credit institutions |
108 |
277 |
- |
385 |
|
633 |
- |
- |
633 |
Minority holdings in property management undertakings |
- |
49 |
- |
49 |
|
- |
52 |
- |
52 |
Other (including hedge funds) |
10 |
84 |
96 |
190 |
|
26 |
115 |
8 |
149 |
Total |
707 |
1,756 |
155 |
2,618 |
|
1,202 |
1,536 |
22 |
2,760 |
Total % |
27.0% |
67.1% |
5.9% |
100.0% |
|
43.5% |
55.7% |
0.8% |
100.0% |
The majority of other shareholder investments, 94%, are classified as Level 1 or 2 (FY09: 99%) in the fair value hierarchy. The unit trusts and other investment vehicles invest in a variety of assets with the majority of the value being invested in Property and Equity securities with a smaller portion being invested in Debt Securities. The key reason for the shift in assets from Levels 1 and 2 to Level 3 has been due to the reclassification of certain investments in hedge funds and other investment vehicles, whose underlying asset mix now includes a significant proportion of Level 3 investments, resulting in the reclassification of the fund as a whole.
_____________________
Page 97
D3 - Analysis of asset quality continued
D3.2.4 - Impairments and amount of unrealised losses on available for sale assets
The total impairment expense for AFS debt securities for HY 2010 was £50 million (FY09: £93 million), of which £49 million relates to our U.S. business. £42 million of the write downs in our U.S. business relate to mortgage backed securities, which are not yet in default, however, continued deterioration in market values is considered an indicator of impairment.
The total impairment expense for AFS equity securities for HY 2010 was £40 million (FY09: £384 million), reflecting the continued recovery of equity markets up to May from their lows in 2009, despite recent reversals.
Total unrealised losses on AFS debt securities at 30 June 2010 were £487 million (FY09: £738 million), and AFS equity securities at 30 June 2010 were £19 million (FY09: £97 million). During the first half of 2010, there has been a further significant decrease in total unrealised losses for AFS securities, continuing the improvement observed in the second half of 2009. We have not recognised an impairment charge in respect of these unrealised losses as we believe the decline in fair value of these securities relative to their amortised cost to be temporary.
D4 - Pension fund assets
In addition to the assets recognised directly on the group's balance sheet outlined in the disclosures above, the group is also exposed to the ''Plan assets'' that are shown net of the present value of scheme liabilities within the IAS 19 net pension deficit. The net pension deficit is recognised within provisions on the group's consolidated statement of financial position.
Plan assets include insurance policies of £162 million and £1,381 million in the UK and Dutch schemes respectively. Where the insurance policies are in segregated funds with specific asset allocations, they are included in the appropriate lines in the table below, otherwise they appear in "Other". The Dutch insurance policies are considered non-transferable under the terms of IAS 19 and so have been excluded as assets of the relevant scheme in this table.
|
30 June 2010 |
|
31 December 2009 |
||||||||
|
United Kingdom £m |
Delta Lloyd £m |
Canada £m |
Ireland £m |
Total £m |
|
United Kingdom £m |
Delta Lloyd £m |
Canada £m |
Ireland £m |
Total £m |
Equities |
2,522 |
- |
58 |
26 |
2,606 |
|
2,285 |
- |
78 |
28 |
2,391 |
Bonds |
4,670 |
- |
140 |
228 |
5,038 |
|
4,619 |
- |
110 |
231 |
4,960 |
Property |
428 |
- |
- |
17 |
445 |
|
403 |
- |
- |
18 |
421 |
Other |
1,090 |
6 |
8 |
114 |
1,218 |
|
835 |
7 |
10 |
130 |
982 |
Total |
8,710 |
6 |
206 |
385 |
9,307 |
|
8,142 |
7 |
198 |
407 |
8,754 |
Risk management and asset allocation strategy
The long-term investment objectives of the trustees and the employers are to limit the risk of the assets failing to meet the liabilities of the schemes over the long term, and to maximise returns consistent with an acceptable level of risk so as to control the long-term costs of these schemes. To meet these objectives, each scheme's assets are invested in a diversified portfolio, consisting primarily of equity and debt securities. These reflect the current long-term asset allocation ranges chosen, having regard to the structure of liabilities within the schemes.
Main UK scheme
Both the Group and the trustees regularly review the asset/liability management of the main UK scheme. It is fully understood that, whilst the current asset mix is designed to produce appropriate long-term returns, this introduces a material risk of volatility in the scheme's surplus or deficit of assets compared with its liabilities.
The principal asset risks to which the scheme is exposed are:
- Equity market risk - the effect of equity market falls on the value of plan assets.
- Inflation risk - the effect of inflation rising faster than expected on the value of the plan liabilities.
- Interest rate risk - falling interest rates leading to an increase in liabilities significantly exceeding the increase in the value of assets.
There is also an exposure to currency risk where assets are not denominated in the same currency as the liabilities. The majority of this exposure has been removed by the use of hedging instruments.
In addition, the trustees have taken measures to partially mitigate inflation and interest rate risks, including entering into inflation and interest rate swaps to hedge approximately one third of the scheme's exposure to these risks.
Other schemes
The other schemes are considerably less material but their risks are managed in a similar way to those in the main UK scheme.
D5 - Available funds
To ensure access to liquidity as and when needed, the group maintains over £2.1 billion of undrawn committed central borrowing facilities with various highly rated banks. £1.0 billion of this is allocated to support the credit rating of Aviva plc's £2.0 billion commercial paper programme. The expiry profile of the undrawn committed central borrowing facilities is as follows:
|
£m |
Expiring in one year |
700 |
Expiring beyond one year |
1,410 |
Total |
2,110 |
D6 - Guarantees
As a normal part of their operating activities, various group companies have given guarantees and options, including investment return guarantees, in respect of certain long-term insurance and fund management products.
For the UK Life with-profit business, provisions in respect of these guarantees and options are calculated on a market consistent basis, in which stochastic models are used to evaluate the level of risk (and additional cost) under a number of economic scenarios, which allow for the impact of volatility in both interest rates and equity prices. For UK Life non-profit business, provisions do not materially differ from those determined on a market consistent basis.
In all other businesses, provisions for guarantees and options are calculated on a local basis with sensitivity analysis undertaken where appropriate to assess the impact on provisioning levels of a movement in interest rates and equity levels (typically a 1% increase in interest rates and 10% decline in equity markets).
End of part 4 of 5